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S U M M A R Y
Phagocytic cells respond to activation by a variety of stimuli by 
generating oxygen-derived free radicals. The characteristics of the 
production of superoxide anion and hydrogen peroxide by human neutrophils 
has been compared with that produced by human monocytes.
The majority of work in this thesis is concerned with the employment of 
an assay which measures hydrogen peroxide produced by stimulated human 
neutrophils in vitro, but which also has been found to detect the 
generation of another peroxide, the identity of which is uncertain.
The use of cyclooxygenase, lipoxygenase and phospholipase A^ pathway 
inhibitors has provided indirect evidence for the identification of the 
unknown peroxide as 5-hydroperoxyeicosatetraenoic acid (5-HPETE). These 
inhibitors have also provided the opportunity to investigate differences 
in the oxidative metabolism of human neutrophils induced by various 
stimuli. In addition, the effects of two cyclooxygenase inhibitors, 
diclofenac and piroxicam, on neutrophil activity in vivo has been 
investigated. Whilst neutrophil activity of some individuals was 
inhibited, this was not consistent and not significant. Incubation of 
a variety of analogues of the cyclooxygenase inhibitors diclofenac and 
fenclofenac with stimulated neutrophils in vitro has allowed an insight 
into the structure-activity relationships of these drugs' effects on 
neutrophil activity. It was found that the position of substitution 
of various groups in the ring structure remote from the acid group had 
the biggest single influence on activity.
Finally, the oxidative metabolism of neutrophils from patients with 
progressive systemic sclerosis, rheumatoid arthritis and peripheral 
vascular disease has been compared with that of neutrophils from healthy 
controls. The neutrophils from the progressive systemic sclerosis group 
were found to have increased activity both ex vivo and following
- 3 -
incubation with heat-aggregated IgG. This has been shown to be 




I N T R O D U C T I O N
In 1882, the Russian scientist Elie Metchnikoff, using living, 
transparent invertebrates for his microscopic studies, discovered 
that there were cells capable of engulfing foreign matter, including 
bacteria. He called this process phagocytosis, literally, "cellular 
eating". It was he who realised that these phagocytic cells were in 
fact protecting the organism and that the acute inflammation which 
occurred at the same time that they appeared was essentially a curative 
response.
The aim of this Introduction is to give an outline of the phagocytic 
cells (chiefly the neutrophils as it is with these cells that the 
majority of the practical work of this thesis is concerned), the 
mechanisms by which they become activated and the consequence of that 
activation. This is followed by an appreciation of the role they play 
in the inflammatory response and in rheumatic diseases, and how non­
steroidal anti-inflammatory drugs may modify their activity.
1. THE NEUTROPHIL
Neutrophils are short-lived end-cells with a high degree of functional 
specialization.
1.1 Structure
Neutrophils in the bloodstream measure approximately 12-1Sum in 
diameter. The darkly-staining nucleus is divided into several sausage­
shaped lobes which vary in number from 1 to 5. These lobes are 
connected to one another by very thin strands of nuclear material 
(Hirsch, 1974; Lisiewicz, 1980). This lobulated structure of the 
nucleus is thought to facilitate exit from the blood vessels as the 
cell can then move through the tight junctions between adjacent
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endothelial cells (Segal, 1981). The cytoplasm contains large numbers 
of round or rod-shaped, membrane-bound granules of two types known as 
azurophil and specific granules. Most of these are usually gathered in 
the centre of the cell between the nuclear lobes. Neutrophils also 
have an abundant flowing plasma membrane with numerous 'ruffles' and 
pseudopods. They are lacking in endoplasmic reticulum and mito­
chondria, but have a microfilamentous network of actin and myosin and 
their related proteins (Segal, 1981).
1.2 Production and Fate
In the adult, neutrophils are produced mainly in the bone marrow and 
arise from a population of stem cells which are also the progenitor 
cells of monocytes, erythrocytes, eosinophils and basophils 
(Quesenberry and Lievitt, 1979). Maturation of the cell proceeds 
through the myeloblast, promyelocyte, myelocyte and metamyelocyte 
stages to juvenile forms and finally the mature marrow neutrophils.
The proliferative stages take about 6 days to complete and maturation 
a further 6 days. Granulopoiesis is regulated by both stimulatory 
and inhibitory factors. The stimulatory factors (granulopoietins) 
include colony-stimulating factors from mononuclear phagocytes, 
activated lymphocytes and the vascular endothelium. Inhibition of the 
maturation of neutrophils has been noted following exposure to inter­
ferons, chemotactic peptides and lactoferrin (Palmblad, 1984). About 
10^^ neutrophils are produced in a normal adult every day (Dancey et
al, 1976) and at any one time in the bloodstream there are about 60 x 
910 neutrophils. Half of these cells are circulating, the other half 
marginate to the lining of the vessels. The two populations appear to be 
in dynamic equilibrium. After about 6 to 7 hours in the circulation 
the cells move into the tissues. Neutrophils marginate and adhere to
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the endothelium. This adherence may be augmented in inflammatory states 
by a plasma factor (Lentnek, Schreiber and MacGregor, 1976) and can be 
inhibited by anti-inflammatory agents (MacGregor, 1976). Following 
adherence the neutrophils crawl between adjacent endothelial cells 
(diapedesis) (Grant, 1974). In the tissues they survive for a few 
days at most. Approximately 10^^ neutrophils (which represent lOOg) 
must disappear from an adult's tissues each day (Palmblad, 1984). The 
methods by which they are destroyed and expelled are poorly understood. 
Suggested sites include lungs, liver, spleen, urine, saliva and 
digestive tract (Lisiewicz, 1980).
1.3 Locomotion and Chemotaxis
Locomotion is similar whether the cells are moving randomly or 
exhibiting chemotaxis. The cell has a pseudopod projected in front, a 
mid-region containing the nucleus and a knob-like tail. The pseudopod 
consists solely of cytoplasm and its protrusion is the first phase of 
locomotion. The second phase involves the translocation of the cell 
nucleus. The pseudopod pulls first the granules and then the nuclear 
segments from the remaining cytoplasm (Zigmond, 1978). Electron 
microscopy studies have revealed a complex arrangement of actin and 
myosin microfilaments just beneath the plasma membrane (Snyderman and 
Goetzl, 1981). These microfilaments are critical for directed loco­
motion and the attendant changes in cellular shape, whereas micro­
tubule rearrangement is required to initiate and stabilize cellular 
orientation toward a chemotactic gradient. Cells treated with agents 
that disrupt microtubules, such as colchicine, exhibit a disorganised, 
non-directional type of movement (Palmblad, 1984).
Chemotaxis can be defined as the ability of motile cells to recognise 
and respond to a suitable concentration gradient with directional
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migration. The classic assay system for chemotaxis was devised by 
Boyden in 1962. He used a two compartment chamber which demonstrated 
the movement of neutrophils through a filter into the compartment 
containing the chemotactic agent. This does not however differentiate 
between true chemotaxis and accelerated random locomotion stimulated 
by that chemotactic agent. Observing and measuring the movements of 
individual cells microscopically gives a more accurate picture. 
Chemotactic factors include products of complement activation (C3a,
C5a), kallikrein, plasminogen activator, leukotriene B^ and in vitro, 
the synthetic peptide n-formyl-l-methionyl-l-leucyl-l-phenylalanine 
(FMLP). It has been suggested that there is a latent plasma factor 
which when activated by superoxide anion, becomes a powerful chemo­
tactic agent (McCord, 1980). Certainly in models of inflammation 
induced in laboratory animals intravenous administration of superoxide 
dismutase, the enzyme which scavenges superoxide, prevents the 
accumulation of neutrophils at the inflammatory locus. This plasma 
factor does not stimulate degranulation or further superoxide 
production and hence does not perpetuate its own existence, but acts 
only as a chemotactic factor, recruiting more cells to the inflammatory 
lesion. However, other workers have not been able to demonstrate the 
existence of this factor. Another chemotactic factor for neutrophils 
is derived from these cells and is induced by crystals. Specific 
binding sites on the cell surface have been demonstrated for this 
glycoprotein (Spilberg and Mehta, 1979). Chemotaxis is initiated by 
the binding of chemoattractants to receptors on the cell surface. One 
means of modulating the sensitivity of cells to chemoattractants would 
be to alter the number, affinity or distribution of receptors along 
the surface of neutrophils during the chemotactic response and there 
is evidence that this does happen (Snyderman and Goetzl, 1981).
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Inhibitors of chemotaxis, which serve to keep neutrophils at the 
inflammatory lesion once they have arrived include the peptide tuftsin; 
neutrophil immobilizing factor and ot ̂  macroglobulin (Goetzl, 1975).
In fact, very high concentrations of chemoattractants themselves 
immobilize neutrophils (Zigmond, 1978). In vitro FMLP may trigger its 
own oxidative inactivation (Clark, 1982). Myeloperoxidase,hydrogen 
peroxide and a halide destroy the biological activity of the peptide 
by oxidation of a methionine residue in an example of a negative feed­
back control mechanism .
1.4 Phagocytosis
Attachment of a particle to receptors on the cell surface brings 
adjacent receptors into contact with that particle. This sequential 
attachment of adjacent receptors results in the plasma membrane being 
pulled up and round the particle to be ingested in what has been 
referred to as a "zipper-like mechanism". This is powered by the 
microfilamentous structures just below the surface of the membrane 
(Stossel, 1974). The phagocytic vacuole which contains the particle 
in a closed sac of inverted plasma membrane is formed when the pseudo­
podia fuse, with subsequent breakage of the neck of the membrane that 
links the phagocytic vacuole with the surrounding plasma membrane 
(Segal, 1981). The fate of the ingested particulate matter is closely 
linked to the process of degranulation and bactericidal killing, both of 
which are discussed later in this Introduction.
1.5 Neutrophil Surface Receptors
The receptors which neutrophils carry on their surface are probably 
glycoproteins, with their protein part embedded in the plasma membrane 
and the carbohydrate moieties sticking out into the extracellular fluid
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acting as specific recognition probes (Roos, 1981) .
Neutrophils bear receptors for the Fc fragment of immune complexes 
and aggregates formed by all IgG and IgA subclasses. They do not have 
receptors for IgM (Henson, 1977). Monomeric immunoglobulin binds only 
weakly to neutrophils although some workers have suggested specific 
receptors for aggregated and monomeric immunoglobulins (Henson and 
Oades, 1975; Treadway et al, 1979) .
Neutrophils also bear receptors for complement components. The best 
studied of these are the receptors for the C3b and C3b' fragments, 
although there are also receptors for C4b; C5b and C5a; small C3 
fragments and C567 (Henson, 1977). Neutrophils carry more Fc receptors 
than C3b receptors (Hed, Stendahl and Sundqvist, 1982). Particles are 
phagocytesable if opsonized by IgG. IgG binds to Fc receptors and 
C3b acts as an amplification in the system. C3b fragments actually 
bind to the Fc portion of IgG and thus accelerate the ingestion of 
IgG-coated particles by binding to their own C3b receptors (Roos, 1981), 
Studies with coated particles show that coating with C3b only, although 
causing membrane perturbation, primarily promotes attachment of the 
particle, whereas coating with IgG primarily affects the ingestion 
phase. IgG-coated particles are 3-4 times more efficient at initiating 
activation of cells than C3b-coated particles (Hed and Stendahl, 1982). 
Wright and Silverstein, (1983), have also reported that while IgG- 
coated particles promote a vigorous release of hydrogen peroxide by 
neutrophils, C3b- and C3b*-coated particles do not.
These studies favour the concept that neutrophils possess different 
types of ingestion and activation mechanisms. One mechanism is 
represented by an IgG-mediated interaction where the antibody mole­
cules, exposing their Fc-portions, become available to interact with 
abundant Fc-receptors on the neutrophil membrane. The initial Fc-
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mediated interaction at the neutrophil surface is accompanied by a 
metabolic activation due to an interaction between Fc receptors and 
the enzyme responsible for oxidative metabolism. As there is no clear 
correlation between C3b-mediated attachment and metabolic activation, 
the receptor for C3b must show a lower association with the enzyme 
responsible for oxidative metabolism, (Hed and Stendahl, 1982; Hed, 
Stendahl and Sundqvist, 1982). The fact that opsonized zymosan does 
stimulate oxidative metabolism in vitro may be due to the fact that it 
is also coated with some IgG as well as with C3b (Hed and Stendahl, 1982) 
Binding of C3b-coated particles to C3b receptors can be completely 
inhibited by the addition of EDTA, or by the omission of calcium and 
magnesium salts from the incubation medium (Roos et al, 1981).
However, the presence of divalent cations does not seem to be 
necessary for the binding of IgG-coated particles to Fc receptors 
(Roos et al, 1981). The function of complement receptors may be 
modified by the impermeant stilbene disulphonic acids (Tauber and 
Goetzl, 1981) as demonstrated by the suppression of superoxide 
production following stimulation of neutrophils pre-treated with this 
agent by opsonized zymosan, and by the inhibition of the expression 
of neutrophil C3b receptors as assessed by a resetting assay. The 
fact that Tauber and Goetzl have found that opsonized zymosan can 
stimulate neutrophil oxidative metabolism, mediated via C3b receptors, 
supports the theory that the receptor for C3b must show a lower 
association with the enzyme responsible for oxidative metabolism 
(Hed and Stendahl, 1982) rather than an inability for C3b receptors to 
mediate oxidative metabolism at all (Wright and Silverstein, 1983).
Many other receptors have also been demonstrated on neutrophils.
Receptors are expressed for the chemotactic peptide FMLP (Williams et 
al, 1977) . The number and affinity of these receptors is increased at
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low sodium concentrations in the medium. This could be due to the 
collapse of the transmembrane potential that occurs when neutrophils 
are suspended in a sodium-free, high potassium medium. The trans­
membrane potential maintains the membrane proteins in a certain 
configuration so that any change could result in new configuration 
states of membrane proteins (De Togni et al, 1983). There are also 
receptors for the tumour promoter, phorbol myristate acetate (Lehrer 
and Cohen, 1981); specific mannoside-containing receptors for conca­
navalin A (Pick and Keisari, 1981); receptors for leukotriene 
(Kreisle and Parker, 1983); cytoplasmic receptors for steroids 
(Jones, Morris and Jayson, 1983); for prostaglandin (Weissmann, 1983) 
and for adenosine (Cronstein et al, 1983). Occupation of these 
receptors stimulates the cell independently of phagocytosis.
2. MONONUCLEAR PHAGOCYTES
In contrast with neutrophils, these phagocytic cells are long-lived 
and capable of differentiation and specialization.
2.1 Structure and Function
Monocytes originate from the same progenitor cells as do neutrophils. 
These stem cells in the bone marrow give rise to the promonocyte 
which in turn gives rise to the monocyte which, after a short maturation 
phase is released into the peripheral blood where it has a half- 
life of 22 hours before passing into the tissues (Quesenberry and 
Lievitt, 1979) . The monocyte is about 14)jm in diameter, has an 
indented nucleus and a moderate amount of cytoplasm which contains 
azurophilic granules. Monocytes have distinctive ruffled membranes
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which are continually in motion and which are involved in the formation
of pinocytic vacuoles (Steinman and Cohn, 1974).
The vast majority of macrophages which accumulate in inflammatory 
areas are of monocyte origin. They can remain in tissues for several 
months in a relatively quiescent state as resident cells. Once
activated they can be categorized into a) Inflammatory macrophages,
which are those stimulated by non-specific inflammatory factors, and 
are high in secretory activity but do not possess enhanced microbicidal 
or tumoricidal activity and b) Activated macrophages, which are those 
stimulated by immunologic factors via lymphocyte-derived products, 
and are low in general secretory activity but possess high activity 
in secreting reactive metabolites of oxygen and thus have micro­
bicidal and tumoricidal activity (Takemura and Werb, 1984). Macro­
phages are larger than monocytes (20-100)im in diameter). Their 
nuclei vary from spherical to deeply indented structures. The 
cytoplasm contains granules and vacuoles. The plasma membrane shows 
increased activity, expressed in an increasing number of surface 
projections (Steinman and Coin, 1974).
As maturation of the mononuclear phagocyte proceeds, the number of 
enzyme-containing granules increases, and hence the macrophage contains 
more enzymes than the monocyte. The level of enzymes differs amongst 
macrophages with an increase indicative of activation. The enzymes 
include many acid hydrolases; neutral proteases such as elastase, 
collagenase and plasminogen activator, complement components and 
lysozyme. Macrophages also secrete enzyme inhibitors such as a^- 
macroglobulin as well as a variety of factors that regulate functions 
of other cells such as interferon and interleukin 1 (Takemura and 
Werb, 1984).
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Macrophages are ^ l e  to phagocytose a much wider spectrum of material 
than neutrophils and can ingest particles smaller than 0.1pm whereas 
the neutrophil is ineffective at this size range.
The ultimate fate of macrophages is not known. It is likely that 
they are lost through the respiratory and digestive tracts, or that 
they are injured and phagocytosed by other macrophages (Steinman 
and Cohn, 1974).
2.2 Mononuclear Phagocyte Surface Receptors
Human monocytes carry receptors for the Fc portion of IgG. Studies 
have suggested that in fact the human monocyte possesses two types of 
Fc receptor, one of high affinity binding monomer and complexes, and 
one of low affinity which predominantly binds complexes (Carter,
Leslie and Reeves, 1982; Rasmussen et al, 1983). Monocytes also carry 
receptors for C3b and C3b', which function independently of one another 
on a single cell. They do not have receptors for C3d. C3b and C3b' 
receptors do not normally mediate ingestion. However, if monocytes 
are first activated e.g. by phorbol myristate acetate, then ingestion 
does occur. The C3b' receptor is three times more efficient in pro­
moting attachment and ten times more efficient in promoting ingestion 
than the C3b receptor (Wright and Silverstein, 1982). As reported for 
neutrophils, neither the C3b nor the C3b' receptor causes the release 




Neutrophil activation in vivo is designed to ensure the ingestion and 
killing of micro-organisms, and the removal of debris, i.e. phagocy­
tosis. However, neutrophils can be stimulated by a variety of means, 
some of which are relevant in vivo, and others which are merely exper- 
mental tools in vitro.
Stimuli which may be relevant in vivo include immunoglobulin, which 
may be in the form of immune complexes or immunoglobulin-coated 
particles. If the particle is too large to engulf, then stimulation 
will result in 'frustrated phagocytosis' (Henson and Oades 1975; 
Johnston and Leymeyer, 1976; Treadway et al, 1979; Gale et al, 1984). 
Another important group of stimuli are particles coated with C3b such 
as crystals (Abramson, Hoffstein and Weissman 1982; Simchowitz,
Atkinson and Spilberg, 1982; Serhan et al 1984), and also the chemo­
tactic peptide C5a (Smith and Iden, 1980). Arachidonic acid (Lew et 
al 1984) and leukotriene (Serhan et al, 1982 (ii); Naccache and 
Sha'afi, 1983) also stimulate neutrophils. In vitro stimuli have been 
used such as aggregated IgG, immunoglobulin-coated surfaces (Henson and 
Oades, 1975; Johnston and Leymeyer, 1976); opsonized zymosan (Roos et 
al, 1981); FMLP (Smith and Iden, 1980); lectins such as concanavalin A 
(Romeo, Zabucci and Rossi, 1973); the tumour-promoter phorbol myris­
tate acetate (Lehrer and Cohen, 1981); lipid or water-soluble iono- 
phores such as calcium ionophore (A23187) (Palmer and Salmon, 1983) , 
and digitonin (Cohen and Chovaniec, 1978) .
From this diverse list of stimuli, it is easy to appreciate that 
neutrophils can be activated without phagocytosis having to take place 
(Goldstein et al, 1975).
The precise details of the series of reactions which accompany cell
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activation, as well as the events following activation, are dependent 
upon the particular stimulus used. There is considerable disagree­
ment in the literature concerning the ability of individual agents to 
stimulate particular aspects of the overall activation process. 
Generally speaking, stimulation of neutrophils leads to aggregation, 
chemotaxis, phagocytosis, secretion of lysosomal enzymes, generation 
of oxygen-derived free radicals and release of lipid products derived 
from membrane phospholipids. 'Stimulus-secretion coupling' is the 
term coined by Weissmann and his colleagues to describe the metabolic 
events which occur once a cell has been activated by contact with a 
stimulus (Weissmann, 1982; Weissmann et al, 1983).
3.2 Events Associated with Cell Activation
Each stimulus produces a slightly different pattern of response but 
generally the following events occur after a ligand-receptor inter­
action: a change in transmembrane potential (Korchak and Weissmann,
1978; Mottola and Romeo, 1982); a loss of membrane-associated calcium 
at the site of interaction and a net accumulation of calcium from the 
extracellular medium (Naccache et al, 1979; Smolen, Korchak and 
Weissmann, 1981); membrane conformational changes and increase in 
membrane fluidity with degradation of phosphatidylinositol and form­
ation of phosphatidic acid and other changes in membrane phospholipids 
(Walsh et al, 1981; Serhan et al, 1982(i); Berridge, 1984); rearrange­
ment of microfilaments and microtubules (Roos, 1981); phosphorylation 
of several proteins (Roos, 1981) and generation of cyclic AMP (Berlin, 
Sand Petersen and Esmann, 1978). These events run in parallel and one 
does not necessarily lead to another.
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3.2.1 Change in Transmembrane Potential
This is due to a change in the partitioning of ions across the cell 
membrane caused by rapid ion fluxes across the membrane. Neutrophil 
stimulation results in a prompt influx of sodium and calcium ions, 
followed by a slow potassium efflux (Romeo et al, 1975; Naccache et al, 
1977; Simchowitz and Spilberg, 1979).
Whether or not an influx of sodium and the associated change in trans­
membrane potential is necessary for triggering neutrophil activation 
is a controversial point. Simchowitz and Spilberg (1979) found that 
FMLP-induced superoxide generation by neutrophils requires the presence 
of sodium ions, whereas Della Bianca et al (1983) reported that neutro­
phils suspended in a sodium-free, high potassium buffered solution 
exhibit much higher respiratory responses than those suspended in a 
physiologically normal medium. This however was only marked at very 
low concentrations of FMLP. Thus it is suggested that sodium ions 
regulate the threshold of responses rather than maximal responses.
Other workers (Korchak and Weissmann, 1980) have also found that a 
reduction in sodium ion concentration depresses superoxide generation 
in neutrophils in response to concanavalin A and immune complexes.
3.2.2 The Role of Calcium in Cell Activation
Calcium ions have long been implicated in the initiation of neutrophil 
activation. At first it was considered that an influx of calcium from 
the extracellular medium was essential for neutrophil activation. This 
was based chiefly on the observation that an absence of calcium ions in 
the medium inhibited the release of certain mediators by particular 
stimuli. For example, it was found that guinea pig neutrophils failed 
to generate superoxide anion when stimulated with digitonin (Cohen and
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Chovaniec, 1977) and that human neutrophils failed to discharge 
lysosomal enzymes when stimulated with opsonized zymosan (Ignarro and 
George, 1974) in the absence of exogenous calcium. Another observation 
which lent weight to this hypothesis was that calcium ions alone 
provoked the release of lysosomal enzymes and that calcium ionophores, 
which facilitate calcium influx, are in themselves stimulatory to the 
cells (Goldstein et al, 1974) . It was also found that increasing 
calcium ion concentration in the medium led to progressive increases 
in superoxide generation whereas the introduction of a calcium channel 
blocker such as verapamil caused a dose-dependent inhibition of super­
oxide production (Simchowitz and Spilberg, 1979).
More recently however it has been shown that, although a calcium influx 
does take place, it is not essential. For instance, although binding 
of C3b to its receptor and of particulate activators of the alternative 
complement pathway to their receptors require calcium in the medium, 
binding of IgG-coated particles does not. Moreover phagocytosis of 
IgG-coated particles and subsequent enzyme release and respiratory 
burst proceed in the absence of calcium ions (Roos et al, 1981). It 
is now believed that it is levels of intracellular free calcium which 
are important. Using fluorescent probes such as chlortetracycline and 
Quin-2 it has been shown that membrane-bound calcium is released intra- 
cellularly upon stimulation of neutrophils with chemotactic factors 
(Naccache et al, 1979; White et al, 1983), with heat-aggregated IgG 
and Concanavalin A (Korchak et al, 1984) or with cytochalasin D and 
E.Coli (Takeshige et al, 1980). In addition, work with intra - and 
extracellular calcium antagonists has supported the hypothesis that 
levels of intracellular calcium are important. Stimulated neutrophils 
secrete lysosomal enzymes and generate superoxide anion, albeit in 
reduced quantities depending on the stimulus, in the presence of EGTA
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(Smolen, Korchak and Weissmann, 1981). However, when the intracellular 
calcium antagonist TMB-8 is used, PMA-induced degranulation and super­
oxide generation are inhibited in a dose-dependent fashion (Smith and 
Iden, 1979; Smith and Iden, 1981) as are calcium ionophore-stimulated 
degranulation and superoxide generation (Matsumoto, Takeshige and 
Minakami, 1979). Thus it appears that neutrophil responses are all 
correlated with, and preceded by, a change in calcium permeability 
which results in the release of calcium from the membrane into the 
cytoplasm. Although an influx of extracellular calcium is not 
essential, it does serve to amplify the responses of the cell and 
different stimuli vary in their efficacy in provoking calcium perm­
eability changes (Korchak, Rutherford and Weissmann, 1984).
Mixtures of stimuli at optimal concentrations do not elicit a 
summation of responses, indicating that interaction of stimuli with 
their respective receptors regulates a common control site of calcium 
translocation (Korchak, Rutherford and Weissmann, 1984). It has 
recently been reported that a calcium efflux also occurs as a 
relatively late event, possibly contributing to the overall regula­
tion of intracellular calcium levels (Korchak et al, 1984).
3.2.3 Changes in the Plasma Membrane
Perturbation of the plasma membrane, whether by attachment of phago­
cytic stimuli to surface receptors, or by direct interaction with the 
membrane results in conformational changes. There is an increase in 
membrane fluidity and this may increase the lateral movement of the 
receptor molecules in the plasma membrane which facilitates the 
circumferential attachment of the receptors to the opsonins on the 
particles (Roos, 1981). Within 15 seconds of stimulation, there are 
extensive changes in specific phospholipid classes (Serhan et al, 1982(i))
- 19 -
Again, the precise details of which phospholipid levels rise and which 
decrease depends upon the stimulus, but neutrophils do rapidly 'remodel' 
their membranes upon activation. For instance, 5 seconds after the 
addition of FMLP, human neutrophil content of phosphatidylcholine, 
phosphatidylserine and phosphatidic acid increase, while the level of 
phosphatidylinositol decreases. Kinetic studies show that only phos­
phatidic acid levels remain elevated. In contrast, when cells are 
exposed to PMA, the levels of phosphatidylcholine and phosphatidylserine 
rapidly increase while changes in phosphatidylinositol and phospha­
tidic acid are not observed until after 60 seconds (Serhan et al,
1982(i)).
3.2.4 Role of Cyclic Nucleotides
Cyclic AMP and agents that raise intracellular levels of cyclic AMP 
inhibit degranulation, whereas cyclic GMP and agents that elevate 
levels of cyclic GMP have the opposite effect (Ignarro and Cech, 1976). 
It was originally thought that there was no change in the levels of 
intracellular cyclic AMP upon neutrophil stimulation and that it was 
cyclic GMP levels that rose (Ignarro and George, 1974). However, the 
assays used were not sensitive enough as Herlin et al (1978) demon­
strated a rise in cyclic AMP levels, 15 seconds after stimulation with 
latex particles, with levels returning to normal after 1 to 2 minutes. 
Again, however, the precise details of cyclic AMP kinetics depend upon 
the stimulus (Smolen, Korchak and Weissmann, 1980), with some agents 
able to stimulate degranulation and oxidative metabolism without causing 
a rise in cyclic AMP.
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4. THE CONSEQUENCES OF CELL ACTIVATION
The events which may occur as a direct consequence of cell activa­
tion are aggregation and adherence, chemotaxis, degranulation, 
oxidative metabolism and arachidonic acid metabolism (Figure 1.1) , 
Aggregation and adherence are briefly mentioned first; chemotaxis has 
been discussed in section 1.3. The biochemical details of degranu­
lation and oxygen-derived free radical production are then discussed 
before being put into the context of their function in vivo, i.e. 
bacterial killing. The relevance of the products of oxidative 
metabolism and arachidonic acid metabolism in mediating tissue damage 
is then discussed in section 7.
Following activation, neutrophils aggregate and adhere to surfaces. 
Dahinden and colleagues have shown that cell surface contact plays an 
essential role in triggering the respiratory burst of neutrophils 
activated by soluble stimuli (Dahinden, Fehr and Hugli, 1983), and 
that, for aggregation to occur, the presence of oxygen metabolites and 
degranulation products are not necessary (Kaplan et al, 1982).
Following activation,neutrophils also become sensitive to chemotactic 
gradients and exhibit chemotaxis, as already described.
4.1 Degranulation
Following interaction of the neutrophils with the inflammatory stimulus, 
the membranes of the lysosomal granules fuse with the plasma membrane 
and the contents of the granules are discharged. If the stimulus has 
been phagocytosed the granule contents are released into the newly 
formed phagocytic vacuole or phagosome (Stossel, 1976). In the 
neutrophil, the granules can be divided into 2 categories. The first 
group, analagous with lysosomes of other tissues ,comprise the azuro­
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Figure 1.1 Events concurrent with Neutrophil Activation
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are formed during the promyelocyte stage of development. They contain 
the acid hydrolases, myeloperoxidase and lysozyme. A sub-class of 
these granules, which are morphologically more heterogeneous and are of 
low density, also contain acid hydrolases, but little or no myeloper­
oxidase. These form 10% to 20% of all the granules. The second group, 
formed during the myelocyte stage of development, are the specific, or 
secondary granules. These are smaller and less dense and contain 
lactoferrin, alkaline phosphatase and some lysozyme. These form 80% 
to 90% of all the granules (Elsbach, 1974; Baggiolini, 1982). Both 
azurophil and specific granules participate in degranulation in 
response to phagocytosis. The specific granules fuse within 3 to 5 
minutes, whereas the azurophil granules fuse after 5 to 10 minutes 
(Hirsch, 1974).
Activation of the plasma membrane by soluble stimuli also causes the 
release of granule contents (Smith and Iden, 1980). This appears to 
affect mainly the specific granules rather than the azurophil granules, 
with the release of large amounts of lactoferrin and lysozyme (Segal,
1981). Phorbol myristate acetate has been shown to stimulate the 
release of the contents of specific, rather than azurophil granules 
(Lisiewicz, 1980). As is the case with the generation of oxygen 
metabolites, calcium has been shown to be important in the process of 
degranulation. Phorbol myristate acetate-induced release of lysozyme 
is inhibited by the intracellular calcium antagonist, TMB-8 (Smith and 
Iden, 1979), whereas the release of 3-glucuronidase and lysozyme in 
response to FMLP, calcium ionophore, concanavalin A, opsonized zymosan, 
heat-aggregated IgG and phorbol myristate acetate proceeds normally in 
the presence of EGTA (Smolen, Korchak and Weissmann, 1981). Calcium ions, 
in the absence of other stimuli, are capable of provoking the release of 
lysozyme from neutrophils in a concentration, time and temperature—
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dependent fashion (Goldstein et al, 1974).
Intracellular cyclic GMP enhances the release of granule enzymes, 
whereas intracellular cyclic AMP inhibits the process (Ignarro and 
George, 1974; Ignarro and Cech, 1976).
Anion transport may also be involved in degranulation because blocking 
of anion efflux inhibits the process (Korchak et al, 1980). As 
degranulation can be restored by the addition of calcium, an explana­
tion could be that the calcium liberated from the membrane pairs with 
the anions, thus decreasing the concentration of free intracellular 
calcium (Roos, 1981).
4.2 Oxidative Metabolism - The Respiratory Burst
Following activation there is a change in oxygen metabolism by neutro­
phils. There is a sharp increase in oxygen uptake, sometimes more than 
50-fold (Babior, 1978); the production of superoxide anion and hydrogen 
peroxide (Babior, Kipnes and Cumette, 1973; Root et al, 1975) and 
the increased metabolism of glucose via the hexose monophosphate (BMP) 
shunt (Nelson et al, 1980).
Although this series of changes is known as the respiratory burst, the 
increase in oxygen uptake is insensitive to inhibitors of mitochondrial 
respiration and hence cannot be explained in terms of increased oxygen 
required to provide ATP as a source of energy for phagocytosis as 
originally thought (Sbarra and Karnovsky, 1959). Rather, all the oxygen 
is utilized to produce superoxide anion (Og") (Weening, Wever and Roos,
1975), via a one-electron reduction using NADPH as the electron donor. 
Superoxide is an oxygen molecule with an extra, unpaired electron in 
an outer orbital:
20_ + NADPH  NADPH ^ 20 ' + NADP* + H*̂2 oxidase 2
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Superoxide is either released into the extracellular environment, or 
it may remain associated with the oxidase system (Segal and Meshulam, 
1979).
Most of the superoxide (80%) is converted to hydrogen peroxide by 
dismutation, and this accounts for practically all the hydrogen 
peroxide formed during the respiratory burst (Root and Metcalf, 1977)V
202* + 2H+  ► BgO, + O2
This dismutation can be spontaneous (especially in acid conditions) or 
accelerated by the ubiquitous cytoplasmic enzyme superoxide dismutase 
(SOD) (Baehner et al, 1975; Fridovich, 1978). At the same time, 
glucose is metabolised through the BMP shunt in order to regenerate 
the NADPH that has been consumed both by the O2 *-forming enzyme, and 
by a glutathione-dependent hydrogen peroxide detoxifying system that 
is found in the cytoplasm of the neutrophil. This system disposes of 
hydrogen peroxide by using it to oxidise glutathione in a reaction 
catalysed by glutathione peroxidase:
2GSH + HgOg  ► GSSG + 28^0
The oxidised glutathione is then reconverted to reduced glutathione 
by the glutathione reductase reaction in which NADP^ is produced 
(Weiss and LoBuglio, 1982):
GSSG + NADPH --------- ► 2GSH + NADP*
4.2.1 The Oxidase Enzyme
The nature and location of the enzyme that catalyses the reduction of 
oxygen to produce superoxide has been the subject of innumerable papers 
in the literature over the last decade. Several oxidases have been
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suggested as responsible (DeChatelet, 1978; Rossi et al, 1982), the 
main two contenders being membrane-bound NADH oxidase and membrane- 
bound NADPH oxidase. There have been a number of approaches attempting 
to isolate and characterize the respiratory enzyme. Several 
different species were employed; resting cells were used by some 
investigators, but stimulated cells by others; and "one enzyme - one 
substrate" was assumed (Badwey, Curnette and Karnovsky, 1979). By 
using subcellular fractions from neutrophil homogenates some labora­
tories put forward the theory that NADH oxidase produced in the 
presence of NADH as substrate (Baehner, Gilman and Karnovsky, 1970; 
Johnston et al, 1975), but the majority view is that NADPH oxidase is 
the enzyme responsible (McPhail, DeChatelet and Shirley, 1976;
Nakamura, Baxter and Masters, 1981; McPhail and Snyderman, 1983).
It appears to be an FAD-requiring enzyme (Babior and Kipnes, 1977) 
which utilizes NADPH as the substrate but it is also capable of using 
NADH, albeit less efficiently (Babior, Curnette and McMurrich, 1976).
It is also hypothesized that the oxidase is a multicomponent electron 
transport system and contains a cytochrome as a second electron carrier, 
There is a b-type cytochrome, found uniquely in phagocytes, which is 
associated with the respiratory burst oxidase (Segal and Jones, 1978,
1979) and it has been shown to be capable of transferring electrons 
from NADPH to oxygen, although whether it is actually on the electron 
transport path between NADPH and oxygen, or whether it plays a role 
in converting the oxidase from its resting to its activated state 
remains to be elucidated (Gabig, Schervish and Santinga, 1982) . Also, 
a quinone, ubiquinone-10, has been found associated with the enzyme 
system and its participation in the initiation of the respiratory 
burst has been postulated (Cunningham et al, 1982).
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The enzyme has long been thought to be associated with the cell 
surface (Goldstein et al, 1977) and is now considered to be embedded 
in the plasma membrane with the NADPH binding site projecting into 
the cytosol and the rest in the lipid bilayer (Dewald et al, 1979;
Babior et al, 1981). What actually activates the enzyme and hence 
initiates the respiratory burst is poorly understood. When the 
isolated particulate fractions containing the enzyme are treated with 
p-diazobenzenesulphonic acid, and then stimulated with FMLP or 
concanavalin A, O^* production is inhibited, but not if phorbol 
myristate acetate or calcium ionophore are the stimulus. Thus it 
appears that more than one mechanism exists for the activation of the 
oxidase (McPhail, Henson and Johnston Jr, 1981). This is supported 
by the observation that, depending upon the stimulus, activation is 
or is not associated with a lag period (McPhail and Snyderman, 1983) 
and by the observations already mentioned that it does or does not 
require a calcium influx; a change in transmembrane potential; 
increments in cyclic AMP or breakdown of phosphatidylinositol. The 
current hypothesis seems to be that the activation of the oxidase 
might be the consequence of a change in the state of phosphorylation 
of an activator protein (Babior, 1984) via protein kinase C. This 
protein kinase C, which is calcium/phosphatidylserine/diacylglycerol 
dependent (De Riemer et al, 1985), is either activated by the increase 
in intracellular calcium concentration or by phosphatidylinositol 
breakdown (Rink, Sanchez and Hallam, 1983). The only stimulus not 
provoking an increase in cytosolic calcium is phorbol myristate acetate, 
but this has been shown to directly activate the protein kinase C 
itself (Niedel, Kuhn and Vandenbark, 1983; De Riemer et al, 1985). It 
has been shown that the enzyme system does require calcium ions for 
full expression of catalytic activity (Green, Wu and Wirtz, 1983).
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In addition, it has been reported that exposure of neutrophils to 
FMLP, before using another stimulus, potentiates the activation of the 
respiratory burst enzyme (Bender, McPhail and Van Epps, 1983) and it 
is FMLP which provokes the greatest increase in calcium permeability 
(Korchak, Rutherford and Weissman, 1984).
Addition of the calcium-binding protein, calmodulin to preparations of 
NADPH oxidase stimulates enzymatic rates and addition of calmodulin 
and calcium,but not calcium aloney to preparations of NADPH oxidase 
inactivated by EDTA results in restoration of activity. This suggests 
a role for calmodulin in the control of the oxidase but not in its 
activation (Jones et al, 1982).
4.2.2 Abnormalities of the Oxidase
There is a complete absence of a respiratory burst associated with the 
neutrophils from patients suffering from the inherited syndrome chronic 
granulomatous disease (CGD) (Johnston et al, 1975; Briggs, Karnovsky 
and Karnovsky, 1977; Segal, 1981). This is considered to be due to a defect 
in the oxidase enzyme and its activity is greatly reduced in particles 
from stimulated neutrophils from patients with CGD (Babior, Curnette 
and McMurrich, 1976; Babior, 1978). Furthermore it has been demon­
strated that there is an absence or a gross abnormality of the cyto­
chrome b in patients with the disease (Segal et al, 1978). The 
implication of this abnormality will be discussed in section 4.2.5 when 
the role of free radical production and degranulation in vivo is 
discussed.
4.2.3 Formation of Hydroxyl Radical
Haber and Weiss proposed in 1934 that a hydroxyl radical could be formed
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from the reduction of by Og*:
^2°2 ------ ^ OH# + o h " + Og
Beauchamp and Fridovich in 1970, were the first to demonstrate that 
OH# could indeed be generated from a reaction between O^* and H^O^/ 
using the enzymatic system xanthine/xanthine oxidase. However, it 
was concluded that this precise reaction could not produce physiologi­
cally relevant amounts of OH# because the rate constant for the inter­
action of 0^• with HgOg is substantially less than that of the 
competing reaction, namely the spontaneous dismutation of Og* . Thus 
although representing the overall stoichiometry of the process, it 
cannot be the reaction mechanism. McCord and Day (1978) proposed a 
modification of the Haber-Weiss reaction in which iron serves as a 
redox catalyst, and the overall reaction is the sum of these reactions;
+ Fe^*  ► Og + Fe^*
2+ 3+Fe + HgOg -----► Fe + OH# + OH#
°2* HgOg  ► + OH# + OH*
The feasibility of this reaction has since been confirmed by others 
(Halliwell, 1978).
There is considerable argument in the literature concerning the 
relevance of this reaction in vivo, and whether there is sufficient 
free iron in extracellular fluids to catalyse the reaction, for unless 
it is present in its 2 valence states, it is unable to participate in 
this reaction. Thus iron as part of cytochromes, haemaglobin and 
catalase would appear unable to catalyse the reaction (Gutteridge, 1982) 
Although iron in animal tissues is largely bound to enzymes or to 
proteins such as transferrin or ferritin, iron ions are moving between
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their storage/transport sites and their sites of use and some of them 
should become attached to the phosphate groups of membrane lipids. 
Biological phosphate esters (e.g. ATP and GTP) can also remove iron 
from protein complexes (Halliwell, 1982). Also micromolar concentra­
tions of non-protein bound iron has been detected in human synovial 
and cerebrospinal fluids (Gutteridge et al, 1982; Rowley et al, 1984). 
Several groups have now reported that OH* can be generated either by 
using isolated NADPH oxidase, utilizing transferrin as the catalyst 
(Bannister et al, 1982) or by using hypoxanthine / xanthine oxidase 
enzymatic system, utilizing transferrin as catalyst (Motohashi and 
Mori, 1983). Other groups have successfully used lactoferrin as the 
catalyst (Ambruso and Johnston Jr., 1981). However, the relevance of 
these experiments may be questioned because they used iron-binding 
proteins fully saturated with iron, which seldom occur in vivo.
Indeed, other groups have been unable to show that protein-bound iron 
does catalyse OH* formation (Winterbourn, 1982). Most recently it has 
been reported that superoxide generated by stimulated neutrophils can 
mobilize free iron from ferritin and thus make it available as a 
catalyst (Biemond et al, 1984). This is especially interesting in the 
light of the finding that rheumatoid synovial fluid contains 9 times 
higher concentration of ferritin than normal synovial fluid (Blake et 
al, 1980). Another argument against iron-catalysed generation of OH* 
being relevant in vivo is the fact that the concentration of superoxide 
present will be much less than that of other reducing agents such as 
glutathione and ascorbic acid which are potentially capable of reducing 
Fe^^ (Winterbourn, 1982). However in vitro it has been shown that 
glutathione does not prevent superoxide and hydrogen peroxide-dependent 
formation of OH* in the presence of iron salts (Rowley and Halliwell,
1982) and that ascorbic acid reacts so rapidly with hydrogen peroxide.
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superoxidë and OH* that it is quickly destroyed (Rowley and Halliwell, 
1983). This might explain the low ascdrbate concentrations found in 
synovial fluid of rheumatoid patients (Blake et al, 1981(i)). The 
relevance of iron-catalysed OH#production to tissue damage will be 
discussed later in section 7.1,2 of this Introduction. The generation 
of oxygen metabolites by stimulated neutrophils is summarised in 
Figure 1.2.
4.2.4 Singlet Oxygen
The outer electrons of oxygen can change their spin and occupy the same 
or different orbitals upon absorption of energy (Badwey and Karnovsky,
1980). Two such excited states of oxygen can be formed and these are 
termed singlet oxygen, ^Og.
When the two outer electrons occupy the same orbital and are of oppo­
site spin this is designated delta singlet oxygen, ^AgO^/ and when the
two outer electrons still occupy separate orbitals, but are of opposite
1 + 1 +spin this is designated sigma singlet oxygen, E gOg. Z gO^ has a
higher energy than ^AgOg and is thus more unstable, having a lifetime
-11 1 -6in solution of 10 seconds whereas AgOg has a lifetime of 2 x 10
seconds (Foote, 1976).
A number of reactions are capable of generating under conditions 
which may be relevant in vivo ;
o j  + H.O.  metal ^ 1q + + oH •2 2 2 2
OCl"* + HgOg  ►  + Cl” + H^O


















Figure 1.2 Generation of oxygen metabolites by stimulated neutrophils,
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Differences in Oxidative Metabolism Between Neutrophils and Mononuclear 
Phagocytes
Monocytes also show an increase in oxygen consumption upon stimulation,
together with production of 0^' and HgOg (Sagone Jr., King and Metz,
1976). However, it has been suggested in comparative studies that 
neutrophils consume 2i times as much oxygen, generate twice as much O^"
and release 5 times as much HgOg as monocytes in response to a phago­
cytic stimulus (Reiss and Roos, 1978). Furthermore, Antimycin A, a 
specific mitochondrial respiratory chain inhibitor, inhibits oxygen 
consumption in monocytes by 70% which would imply that only 30% of the 
oxygen consumed by activated monocytes is converted to and 70% is
metabolized by the mitochondrial respiratory chain. In studies using 
phorbol myristate acetate and micropore filters coated with aggregated 
IgG, the release of " from monocytes was about two-thirds that from 
neutrophils from the same donor (Johnston, Lehmeyer and Guthrie, 1976). 
There is some evidence to suggest that macrophages from mouse bone 
marrow may use NADH oxidase as the respiratory enzyme rather than NADPH 
oxidase (Hovestadt and Ferber, 1984).
4.2.5 Microbicidal Killing
Whilst phagocytosis ensures the sequestration of potentially harmful 
microorganisms, they still have to be killed to prevent replication and 
consequent spread of infection, and it is the purpose of the respiratory 
burst to provide a battery of oxidizing agents that can be used by the 
phagocyte for the destruction of microorganisms. Patients with chronic 
granulomatous disease, where there is an absence of any respiratory 
burst, suffer a high incidence of recurrent infection, which underlines 
the importance of reactive oxygen metabolites in microbicidal killing 
(Segal, 1981).
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Superoxide itself is probably not bactericidal as it is only weakly 
reactive (Badwey and Karnovsky, 1980) and has a half-life, in the 
presence of SOD, of only 5 milliseconds (Greenwald, 1981). It is 
HgOg which is important in bacterial killing. It has itself a certain 
amount of bactericidal potency, but this is greatly augmented through 
the action of the enzyme myeloperoxidase (Klebanoff, 1967; Rosen and 
Klebanoff, 1979). This haemoprotein is present in the azurophilic 
granules of neutrophils and monocytes (Babior, 1978). It catalyzes 
the oxidation of halide ions to hypothalite ions by HgOg.
X' + HgOg  ► XO" + H^O
Cl , Br and I can all be oxidized by this enzyme, but it is likely 
that Cl is the physiologic substrate, since it is by far the most 
abundant halide in the cell, being present in neutrophils at a 
concentration of approximately 90mM (Badwey and Karnovsky, 1980).
The mechanism by which hypochlorite is bactericidal may be due to 
halogénation of the bacterial cell wall. Hypochlorite is itself an 
exceedingly powerful microbicidal agent and it is also the precursor 
of the choramines, a group of microbicidal oxidized halogens that are 
formed by the reaction between hypochlorite and ammonia, or amines 
(Babior, 1984):
OCl” + RNH^ -------- ► RNH^Cl + OH'.
The myeloperoxidase system is also able to decarboxylate amino acids, 
converting them to aldehydes, carbon dioxide and ammonia :
R-CHNH^ - COOH ------- ► R-CHO + CO^ + NH^
The aldehydes thus formed may be toxic. Recently it has been suggested
that myeloperoxidase in this system can be replaced by Fê "*” and the 
chloride ions with iodide ions (Klebanoff, 1982). It is proposed that
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2+Fe and HgOg generate OH*, which interacts with iodide to form one 
or more toxic species, as well as being a potential microbicidal agent 
itself. This mechanism could be important in patients with myelo­
peroxidase deficiency, many of which are in fact asymptomatic (Segal,
1981). Myeloperoxidase-deficient cells show an enhanced respiratory 
burst when compared with normal cells, which supports this theory 
(Dri et al, 1984).
The killed organisms are subsequently digested and degraded by the 
proteolytic enzymes released upon degranulation. Lysozyme attacks 
the mucopeptide of cell walls of some species (Stossel, 1976). The 
phagocytic vacuoles start to swell, resulting from the attraction of 
water into the vacuoles by osmosis. As the vacuoles swell they fuse 
with each other and the plasma membrane and then exocytose the 
partially degraded organisms and digestion products to the exterior 
(Segal, 1981).
4.3 Arachidonic Acid Metabolism
The recognition that the plasma membrane is the site of reception, 
modulation and transfer of signals that lead to the cell's responses 
has aroused much interest in the possible role of membrane phospho­
lipids in trans-membrane signalling.
The neutrophil is an example of a cell thought to undergo phospholipid 
modification upon stimulation with déacylation and reacylation and a 
liberation of unsaturated fatty acids (Stocker and Richter, 1982) .
The 20-carbon polyunsaturated fatty acid arachidonic acid is released 
from membrane phospholipid, particularly phosphatidylinositol and 
phosphatidylcholine (Walsh et al, 1981) . Under resting conditions the 
cells contain little if any free arachidonic acid (Naccache and Sha'afi, 
1983) . It is released from its esterified form by phospholipase A„
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(Walsh et al, 1983). This calcium - and calmodulin-dependent enzyme 
(Stocker and Richter, 1982) has been shown to be associated with the 
membrane of human neutrophils (Franson et al, 1977; Victor et al, 1981) 
and thus is present in a strategic location at the cell surface. 
Phospholipase releases arachidonic acid and lysophospholipids 
(Englberger, Bitter-Suermann and Hadding, 1984). Free arachidonic 
acid is rapidly converted to sets of biologically active compounds - 
prostaglandins, thromboxanes and leukotrienes. The synthesis of 
prostaglandins and the thromboxanes is initiated by 11-cyclooxygenase 
and the synthesis of the leukotrienes by the iron-containing dioxygen­
ases, the lipoxygenases (Taylor and Morris, 1983). In neutrophils, 
the metabolism of arachidonic acid proceeds predominantly through the 
5-lipoxygenase pathway (Naccache and Sha'afi, 1983). Recently a 15- 
lipoxygenase has also been described (Samuelsson, 1983) and several 
other lipoxygenases with differing positional specificities have been 
identified in other cell types. Figure 1.3 illustrates the major 
pathways of arachidonic acid metabolism.
4.3.1 The 11-Cyclooxygenase Pathway
The initial step in the metabolism of arachidonic acid by 11-cyclooxy­
genase is the addition of molecular oxygen to give the endoperoxide 
PGG^. This is rapidly transformed to the hydroxyendoperoxide PGH^, 
with the liberation of an oxygen-derived free radical. Once the endo- 
peroxides have formed, they have a very short half-life in cells and 
fluids and they become transformed into prostaglandins, prostacyclin 






























Figure i.3 Metabolism of Arachidonic Acid
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4.3.2 The 5-Lipoxygenase Pathway
The initial step in the metabolism of arachidonic acid by 5-lipoxy- 
genase is the formation of the 5-hydroperoxy derivative. This can 
either be spontaneously hydrolysed to form the 5-hydroxyeicosatetra- 
enoic acid (5-HETE) or be enzymatically converted to an unstable 
epoxide, leukotriene A^, that reacts rapidly with water to form 
leukotriene a dihydroxy-derivative of arachidonic acid. In the 
presence of glutathione, leukotriene A^ is converted to leukotrienes 
C^, and E^. Leukotriene B^ has been shown to be W-oxidized to form 
20-OH leukotriene B^ which can be further metabolized to the dicarbo-
xylic acid 20-CCX)H-leukotriene B^ (Piper, 1984).
The structures of the metabolites of the 5-lipoxygenase pathway are 
given in Figure 1.4. Leukotriene B^ thus formed is now capable of 
stimulating neutrophils themselves and thus a perpetuating cycle of 
activation may well be set up.
Leukotriene B^ is a potent and multifunctional neutrophil stimulus
(Naccache and Sha'afi, 1983). It stimulates chemotaxis and aggregation 
(Prescott, Zimmerman and Seeger, 1984). It can also stimulate degran­
ulation, oxygen uptake and superoxide generation, dependent on calcium 
in the medium (Sumimoto, Takeshige and Minakami, 1984) although it is 
not as potent as FMLP (Palmblad et al, 1984). The fact that an inhibi­
tor of leukotriene synthesis, U-60 257 also inhibits degranulation and 
superoxide generation suggests that LTB^ might function to mediate 
neutrophil activation (Smith et al, 1982). This activity is probably 
related to its ability to mobilize calcium by essentially the same 
mechanisms as chemotactic factors such as FMLP i.e. it causes a rapid 
rise in intracellular calcium due to both an extracellular influx and 
release from intracellular pools (Naccache et al, 1984; Lew et al, 1984; 
Becker et al, 1981),
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Figure 1.4 Products of the 5-lipoxygenase pathway derived from 
arachidonic acid.
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Whereas the products of the lipoxygenase pathway, especially LTB^, are 
capable of stimulating further neutrophil responses, the products of 
the cyclooxygenase pathway are not. Prostaglandins of the E series and 
prostacyclin all inhibit superoxide production and LTB^ production 
(Fantone and Kipnes, 1983; Ham et al, 1983). This may well be linked 
with the fact that these prostaglandins raise levels of cyclic AMP 
within cells.
5. IMPORTANCE OF FREE SULPHYDRYL GROUPS FOR NEUTROPHIL FUNCTION
Both penetrating sulphydryl group inhibitors such as mercuric chloride 
and N-ethyimaleimide, and surface sulphydryl group inhibitors such as 
para-hydroxymercuriphenylsulphonic acid (pHMPSA) have been used to 
discover the role of sulphydryl groups in various neutrophil functions. 
Penetrating sulphydryl group inhibitors have been found to inhibit 
neutrophil adhesiveness, motility, phagocytosis and superoxide produc­
tion (Giordano and Lichtman, 1973; Tsan, Newman and McIntyre, 1976; 
Cohen and Chovaniec, 1978) . Surface sulphydryl group blockers inhibit 
HMP shunt activity (Tsan et al, 1976) but their reported effects on 
oxidative metabolism is conflicting. Giordano and Lichtman claim that 
pHMPSA has no effect on any neutrophil function, whereas Tsan, Newman 
and McIntyre claim that whilst pHMPSA has no effect on superoxide 
production, it, does inhibit HgOg production.
There has been interest in the role of serine proteases (or esterases) 
on neutrophil and mononuclear phagocyte functions. Using potent 
inhibitors or synthetic substrates of serine esterases, several studies 
have shown that protease activity may be essential for superoxide 
production (Kitagwa, Takaku and Sakamoto, 1980; Hoffman and Autor, 1982) 
and it has been suggested that the protease involved in the production
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of " is a chymotrypsin - or trypsin-like serine esterase. These 
inhibitors are potent sulphydryl group inhibitors and it is now 
suggested that their effects may be due to this fact (Kitagwa, Takaku 
and Sakamoto, 1980). This is further substantiated by the fact that 
inhibition of production by neutrophils by these inhibitors can 
be prevented by GSH (Tsan, 1983).
6. ROLE OF NEUTROPHILS IN MEDIATING THE INFLAMMATORY PROCESS
It is important to appreciate that acute inflammation is essentially a 
curative process for damaged tissue. Sometimes, however, instead of 
resulting in healing, inflammation becomes chronic, resulting in 
gradual destruction of tissue.
When tissue is injured, a host of inflammatory mediators from mast cells, 
disruption of blood vessels and damage to cells are released. These 
mediators cause vasodilation and increased vascular permeability 
leading to vascular leakage. Such mediators from plasma include 
kinins (e.g. bradykinin) and C5a. Those released from tissues include 
histamine, 5-hydroxytryptamine (5-HT), LTB^ and prostaglandins (Ryan 
and Majno, 1977). It has also been suggested that neutrophils, 
responding to chemical signals in the tissue such as LTB^ or C5a can 
control the permeability of the blood vessel wall to plasma proteins 
(Wedmore and Williams, 1981). The vascular leakage results in 
swelling which feels hot, painful and is associated with redness, and 
is due to leakage of plasma into the tissues. Further factors in 
this plasma which perpetuate the inflammatory process include comple­
ment components and components of the clotting system. All these 
mediators will attract neutrophils and recruit them to the site of the 
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acute inflammatory exudate. Circulating neutrophils exhibit increased 
adherence to endothelial cells in the vicinity of the lesion. This 
enhanced stickiness of the endothelium appears to be a prerequisite 
for their subsequent emigration into the tissues. They penetrate 
the vessel wall and squeeze between the endothelial cells (diapedesis) 
into the surrounding tissues. This takes between 2 and 12 minutes.
Once they have arrived at the place where the concentration of the 
chemotactic factors is high, neutrophils respond by significant release 
of granule enzymes, oxygen metabolites and leukotrienes, all further 
mediators of inflammation. High concentrations of chemoattractants 
tend to reduce the motility of the cells and hence increasing numbers 
of neutrophils tend to become immobilized in such an environment 
(Zigmond, 1978). Stimulated neutrophils have been shown to induce the 
release of prostacyclin from cultured endothelial cells (Harlan and 
Callahan, 1984). Prostacyclin has a pro-inflammatory action and 
enhances oedema formation due to the vasodilation it causes. Cells 
from CGD patients do not have this effect and the presence of catalase 
significantly inhibits prostacyclin release, which implies that HgOg 
generation is responsible. As quinacrine inhibits the release of 
prostacyclin, it is suggested that HgOg acts by triggering endothelial 
cell membrane phospholipase.
Thus, inflammation is a self-perpetuating process, and continues until 
the stimulus is removed. This "vicious circle" of events is shown in 
Figure 1.5.
7. THE ROLE OF NEUTROPHILS IN MEDIATING TISSUE DAMAGE IN RHEUMATIC 
DISEASES
7.1 Rheumatoid Arthritis
Rheumatoid arthritis is an example of a disease where there appears to
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be insufficient control over the inflammatory process. It is a systemic 
disease of connective tissue which affects mainly the peripheral 
synovial joints. Symmetrical joints are affected and are most 
commonly the proximal, interphalangeal and metacarpophalangeal joints, 
wrists, metatarsophalangeal joints and the knees. Age of onset is 
usually between 25 to 55 and 3% of women and 1% of men in the total 
population are affected. There may be a family predisposition to the 
disease and its severity is associated with an increased frequency of 
the HLA antigen DR4. In addition, those having the DR3 antigen have 
a more aggressive disease (Holland and Jayson, 1981). The cause of 
RA is unknown. It is thought that, in a genetically predisposed 
individual, some antigenic environmental trigger stimulates the 
production of auto-antibodies. Tissue damage results from immune 
complex deposition in the synovium and blood vessel walls followed by 
activation of complement and release of inflammatory mediators such as 
enzymes and oxygen-derived free radicals from phagocytic cells 
(Zvaifler, 1971; Movat, 1979). During episodes of active arthritis 
the joints are painful and swollen with loss of movement and function. 
This is most apparent on waking and gives rise to 'early morning 
stiffness'. These features are due to synovial inflammation, oedema 
and hypertrophy and the development of joint effusions. As the 
patient finds the most comfortable position is for the inflamed joint 
to be flexed, fixed flexion deformities can arise and weakening of the 
joint capsule and tendon along with ligament damage leads to instability 
and subluxation. Eventually severe joint damage may lead to fibrous 
or bony ankylosis or secondary degenerative changes as the arthritis 
becomes chronic (Holland and Jayson, 1981).
Other features of the disease include rheumatoid nodules, which are 
granulomatous masses found at pressure areas. Their presence indicates
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severe disease. Common systemic symptoms of the disease include 
weight loss and anaemia (Panayi, 1980).
7.1.1 The Synovium
When the synovium becomes inflamed, finger-like villi are formed in 
the synovial tissues. Synovial cells undergo hyperplasia, accompanied 
by cell hypertrophy and multinucleate giant cell formation. There is 
infiltration of the subsynovial tissue by monocytes, plasma cells and 
small lymphocytes (Vernon-Roberts, 1980). Rheumatoid synovial cells 
show increased PGE^ and collagenase production (McGuire et al, 1982; 
Baker et al, 1983) due to the action of a monocyte-derived factor 
which is probably related to Interleukin I . As inflammation proceeds 
the inflamed synovial villi proliferate and spread over the joint 
surface as pannus. This progresses from the joint periphery towards 
its centre, eroding cartilage and bone along its path. The pannus 
may then become fibrous, restricting movement of the joint (Figure 1.6). 
Active disease is accompanied by an increase in the amount of synovial
fluid. Normally in the knee, only about 2ml is present which is clear,
pale yellow, highly viscous and contains few cells. But in an inflamed 
joint the fluid is cloudy and much less viscous.
The rheumatoid synovium synthesizes IgG which may be involved in local
immune complex formation. It has been shown that some immune complexes
become trapped in the rheumatoid articular cartilage. Samples of this 
cartilage, when incubated with normal neutrophils, stimulate those 
neutrophils to become attached and invade the cartilage in an attempt 
to phagocytose the immune complexes. This can cause damage to cartilage 

















Figure 1.6 Degenerative changes in an inflamed joint
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Immune complexes in synovial fluid activate complement and this 
stimulates an enormous influx of neutrophils. Neutrophils constitute 
over 90% of cells found in the synovial fluid and leukocyte counts of 
50,000/mm^ are not unusual. These cells have a half-life of 3 to 4 
hours in the joint, thus each day over one billion cells enter the 
joint to participate in the inflammatory response. Neutrophils ingest 
the immune complexes with the concomitant release of hydrolytic 
enzymes (Zvaifler, 1971), oxygen metabolites and leukotriene 
(Davidson, Rae and Smith, 1983).
7.1.2 Role of Oxygen-Derived Free Radicals
Oxygen-derived free radicals are capable of mediating a wide variety 
of tissue damage much of which would be relevant in rheumatoid 
disease. Oxygen metabolites, either produced enzymatically, from 
stimulated neutrophils, or by the autooxidation of ferrous salts 
(Gutteridge, 1982), have been shown to damage cultured endothelial 
cells (Weiss et al, 1981, Niwa et al, 1982); to cause red cell lysis 
and liposome oxidation (Kellogg III and Fridovich, 1977); to mediate 
collagen breakage (Monboisse, Braquet and Borel, 1984); to inhibit 
serum anti-protease activity (Greenwald, 1981); to depress lymphocyte 
reactivity, which might explain the disturbed immuno-reactivity of 
synovial fluid lymphocytes in RA (Niwa et al, 1983); and to damage the 
phagocytic cells which have produced them (Salin and McCord, 1975; 
Sweder van Asbeck et al, 1984). Studies in several laboratories have 
shown that hyaluronic acid is susceptible to oxygen-derived free 
radical damage (McCord, 1974; Puig-Parallada and Planas, 1978; Del 
Maestro et al, 1980; Greenwald and Moy, 1980). Hyaluronic acid is 
the glycosaminoglycan that accounts almost entirely for the viscosity
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of synovial fluid and there is good reason to believe that oxygen- 
derived free radicals (probably OH*) bring about depolymerization of 
hyaluronic acid and thus cause the reduction in synovial fluid 
viscosity seen in an inflamed joint (Greenwald and Moy, 1980). It is 
recognised that one mechanism by which neutrophils could damage all 
these different tissues is by lipid peroxidation induced by radicals 
(Kellogg III and Fridovich, 1975; Kellogg III and Fridovich, 1977;
Dixit,Mukhtar and Bickers, 1982). OH* is capable of initiating lipid 
peroxidation by its ability to abstract hydrogen atoms from the 
allylic position of unsaturated lipid to yield hydroperoxides 
(Figure 1.7) (Badwey and Karnovsky, 1980). The radical (R*) formed 
may then initiate a chain reaction. Singlet oxygen (^Og) has also 
been shown capable of mediating lipid peroxidation. As the delta form 
has an unoccupied outer orbital, it behaves as a strong electrophile 
and reacts avidly with molecules that contain regions of high electron 
density such as carbon-carbon double bonds (Badwey and Karnovsky, 1980), 
The conjugate acid of Og", perhydroxyl radical (HO*) reacts with 
linolenic, linoleic and arachidonic acids and could also be implicated 
in oxygen-derived free radical toxicity (Bielski, Arudi and Sutherland,
1983) .
It has been suggested (Morehouse et al, 1982) that oxygen-derived free 
radicals are not the predominant means by which lipid peroxidation 
occurs, because addition of exogenous catalase to their system in vitro 
failed to alter the rate of lipid peroxidation. However, this may be 
artefactual and explained by work by Gutteridge and colleagues who 
showed that catalase itself can react non-specifically with lipid 
peroxides, decomposing them as they are formed (Gutteridge, Beand and 
Quinlan, 1983). Thus, if oxygen-derived free radicals can cause 
damage in RA via lipid peroxidation, one would expect to see peroxi-
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Figure 1.7 OH* mediated lipid peroxidation
+ R#
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dation products in the synovial fluid of RA patients. This is indeed
the case, as lipid peroxidation products have been found at increased
levels in patients with inflammatory disorders (Lunec et al, 1981;
Rowley et al, 1983). In addition, in order for the oxygen-derived
free radicals to be implicated in mediating tissue damage, iron would
need to be present and has indeed been detected (Gutteridge, Rowley
and Halliwell, 1982). It has been found that the amount of lipid
peroxidation products present in the synovial fluid of rheumatoid
patients correlates with the concentration of iron salts present and
with disease activity (Rowley et al, 1983). Moreover, lipid
peroxidation is inhibited by the iron chelator desferrioxamine as is
iron-catalyzed formation of OH*. High doses of desferrioxamine given
intraperitonealy suppresses inflammatory reactions in animal models
(Gutteridge, Richmond and Halliwell, 1979; Blake et al, 1983(ii)),
further implicating the activity of OH* and iron in mediating tissue
damage. Recently it has been reported (Blake et al, 1985(i)) that
Vorw
the administration of intravenous dextran to RA patients for the 
treatment of anaemia resulted in the exacerbation of synovitis, with 
a concomitant increase in lipid peroxidation products in the synovial 
fluid.
Oxygen-derived free radicals produced enzymatically or by neutrophils 
have been shown to be capable of aggregating IgG in vitro Wickens et 
al, 1981; Lunec, 1984; Wickens and Dormandy, 1984). Neutrophils may 
then respond to this aggregated IgG by producing more free radicals 
and thereby perpetuating the process. The aggregated IgG is identical 
to fluorescent aggregates isolated from rheumatoid sera and synovial 
fluids which in turn activates normal neutrophils (Gale et al, 1983).
It has also been suggested that IgG aggregates in vivo may be generated 
by the myeloperoxidase-hydrogen peroxide system (Jasin, 1983).
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Neutrophils from patients with rheumatic diseases have been compared 
with cells from healthy controls with somewhat conflicting results.
Niwa and colleagues have found increased oxygen-radical generation 
from neutrophils from patients with RA as compared with controls 
(Niwa et al, 1983) and also from patients with Behcets disease which 
is a form of seronegative arthritis characterized by recurrent oral 
and genital ulcers (Niwa et al, 1982). However, others have found 
no difference in the * generating power of neutrophils from RA 
patients and controls (Chui et al, 1983; Minty et al, 1983), but have 
found a depression in production by neutrophils from patients 
with Felty's syndrome which is a complication of severe RA character­
ized by neutropenia and splenomegaly (Chui et al, 1983). Neutrophils 
from patients with rheumatoid arthritis show a marked reduction in 
directed motility. This is thought to be due to immunoglobulin 
inclusions as the number of inclusions in cells from these patients 
is inversely proportional to their chemotactic activity (Goddard et 
al, 1984).
7.2 Progressive Systemic Sclerosis
P.S.S. is a connective tissue disease of unknown aetiology that is 
characterized by the excessive accumulation of collagen in the skin 
and internal organs such as oesophagus, heart, lungs and kidneys 
(Jimenez, 1983). This accumulation of collagen is thought to involve 
an alteration in the regulation of collagen biosynthesis by fibroblasts 
The fibroblasts may be directly activated or else some factor in the 
disease is causing a process of selection of fibroblasts programmed to 
producing increased amounts of collagen (Botstein, Sherer and LeRoy,
1982). The skin lesion evolves through an oedematous phase containing
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lymphocyte infiltrates and culminates in a taut, hidebound appearance 
characteristic of fibrosis.
There may be a poly-arthritis affecting the small joints of the hands 
and soft tissue swelling due to a subacute synovitis. Patients with 
P.S.S. frequently have Raynaud's phenomenon (Buckingham et al, 1980). 
The disease usually presents between 30-50 years of age and women are 
affected about twice as often as men. About 30% of patients have 
skin involvement localized to distal extremities (sclerodactyly); 30% 
have skin involvement localized to mid-forearm, mid-calf or face 
(acrosclerosis); 15-20% of patients, as well as having distal involve­
ment have involvement of the trunk (diffuse disease). This latter 
group have the more severe systemic disease (Maddison,Personal 
Communication). Serological abnormalities include the presence of 
antinuclear and other auto-antibodies (Whiteside et al, 1983). 
Pathological abnormalities include damage to the endothelial cells of 
the microvasculature, arterial changes and abnormalities in capillary 
structure (Shanahan Jr., and Korn, 1982). It has been suggested that 
there is a functional defect in serum protease inhibitors (Kahaleh 
and LeRoy, 1983) and a build up of a serum protease cytotoxic factor 
active against endothelial cells is reported in 50% of cases (Shanahan 
Jr. and Korn, 1982; Cohen, Johnson and Hurd, 1983). It has also been 
reported that the factor responsible for endothelial cell cytotoxicity 
may be an oxidized lipoprotein (Blake et al, 1985(ii)). Also reported 
is the occurrence of increased frequency of chromosome breakage and 
rearrangement in cell cultures of blood and skin from P.S.S. patients 
(Sherer et al, 1981).
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Figure 1.8 Implication of free radicals and peroxides in systemic 
sclerosis.
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7.2.1 Implication of 0^-Derived Free Radicals and Products of
Arachidonic Acid Metabolism in the Pathogenesis of P.S.S.
How Og-derived free radicals may be implicated in P.S.S. is shown in 
Figure 1.8. Free radicals, either generated enzymatically or derived 
from activated neutrophils are capable of mediating endothelial cell 
damage (Del Maestro et al, 1980; Weiss et al, 1981). One of the 
mechanisms for functional defects in serum protease inhibitors is by 
direct damage by neutrophil-derived oxygen free radicals, which would 
lead to a build up of serum cytotoxic factor (Carp and Janoff, 1979).
If oxidized lipoprotein is responsible for cytotoxicity, neutrophil- 
derived free radicals are suitable oxidants. It has also been shown 
that DNA suffers covalent bond cleavage on exposure to hydroxyl 
radicals (Mello Filho and Meneghini, 1984). It has been reported that 
patients receiving the anti-neoplastic drug bleomycin have developed 
a cutaneous fibrosis"indistinguishable from that encountered in P.S.S." 
(Finch et al, 1979), although this point appears contentious. Bleomycin 
is known to generate free radicals and also induces chromosome cleavage 
(Tom and Montgomery, 1980) which can be inhibited by SOD (Galvan et al, 
1981) .
8. INHIBITORS OF OXYGEN-DERIVED FREE RADICAL-MEDIATED DAMAGE IN VIVO
8.1 SOD
Superoxide dismutase was first described by McCord and Fridovich in 
1969 who recognised it as the active enzyme in copper-containing 
proteins isolated from human and bovine sources. They demonstrated 
its use in preventing O^"-mediated reactions. As the product of the 
dismutation of which it catalyses is H2O2/ also a potentially
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hazardous agent, its only value in vivo would seem to be in the 
prevention of the formation of OH*, formed in the reaction between 
O^' and HgOg. SOD has been given intravenously and shown to be 
effective against various inflammatory diseases such as RA, 
dermatomyositis and lupus erythematosus (Bragt, 1984). Intra- 
synovial administration of SOD in the form of orgotein, the generic 
name for drug versions of CuZn superoxide dismutases has proved 
effective in relieving symptoms of RA (Goebel, Storck and Neurath,
1981). However, in vivo, the protection offered by extracellular 
endogenous SOD is minimal. SOD is either completely absent (Blake 
et al, 1981) from rheumatoid synovial fluid, or else is present in 
negligible amounts (Biemond, Swaak and Koster, 1984). In recent 
experiments, i.v. administration of rat SOD to rats with adjuvant 
arthritis has proved ineffective as an anti-inflammatory agent. Rat 
SOD is manganese-containing, and it is now suggested that the anti­
inflammatory activity of CuZn SOD is due to the presence of copper 
(Halliwell, Personal Communication).
8.2 Catalase
Catalase is capable of detoxifying HgOg, reducing it to water:
«2°2 + «2 °2  " 2^2° + °2
However, Blake et al found low concentrations of catalase in RA 
synovial fluid and, although Biemond et al found a significant increase 
in the levels of catalase in RA synovial fluids compared with controls, 
the concentration is too low to expect considerable protection against 




It was originally thought that caeruloplasmin, the copper-containing 
protein, an acute-phase reactant, had a SOD-like activity in that it 
scavenged * radicals (Goldstein et al, 1979; Goldstein et al, 1982) . 
However, this claim has been refuted by many groups, Bannister et al 
found that the rate of disappearance of is not markedly increased 
by the presence of caeruloplasmin and that there was no evidence for 
any accelerated dismutation comparable to that caused by SOD 
(Bannister et al, 1980). It is now agreed that the anti-oxidant 
activity of caeruloplasmin is due to its ferroxidase activity. It 
inhibits ferrous ion-stimulated lipid peroxidation and ferrous ion- 
dependent formation of OH* by catalysing the reaction Fê "*"— Fe^*. 
Thus any free iron in extracellular fluids would be kept in Fe^^ state 
(Gutteridge, Richmond and Halliwell, 1980; Gutteridge, 1983). It also 
prevents copper ions from stimulating lipid peroxidation. It is 
present in elevated amounts in sera from RA patients compared with 
controls (Blake et al, 1983(i); Biemond, Swaak and Koster, 1984) and 
so it may act as a protective factor, but although synovial fluid 
from RA patients contains caeruloplasmin, its ferroxidase activity is 
low. This deficiency may contribute to radical damage in the joint.
8.4 Vitamin E
Vitamin E is a powerful anti-oxidant in vitro, but its importance in 
this capacity in vivo in man is questionable. In animals, vitamin E 
deficiency is always associated with an increased susceptability to 
free-radical oxidation and at least one human disease - a haemolytic- 
thrombocytopenic syndrome in prematurely born infants - responds to 
vitamin E (Dormandy, 1978).
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9. ACTION OF NSAIDS AND INHIBITORS OF ARACHIDONIC ACID METABOLISM 
ON NEUTROPHIL FUNCTION
There are many non-steroidal anti-inflammatory drugs used in the 
treatment of RA to reduce inflammation and pain (see Figure 1.9). The 
possible action of these drugs in vitro on phagocytic cell function as 
well as on synovial fluid degradation induced by free radicals has 
been the subject of many studies. It is widely believed that the 
ability of these drugs to suppress inflammation is due to their action 
as cyclooxygenase inhibitors, for PGEg plays a major role in the 
development of inflammatory erythema, oedema and pain (Higgs and Vane,
1983). However, this alone would not be effective in preventing the 
inflammation caused by other mediators which are released from activated 
phagocytic cells and NSAIDS may act in other ways on the cells. The 
results of the studies are conflicting and often depend upon the type 
and origin of the cells used, the stimulus employed and the concentra­
tion range of the drug in question. These are all summarized in Table 
1.1. Generally it has been found that, in vitro, benoxaprofen (lipoxy- 
genase/cyclooxygenase inhibitor) inhibits neutrophil chemotaxis and 
phagocytosis (Wildfeuer, 1983; Anderson et al, 1984; Turner et al, 1984). 
Diclofenac sodium and phenylbutazone (cyclooxygenase inhibitors) also 
inhibit chemotaxis (Perianin, Labro and Hakim, 1982; Wildfeuer, 1983) 
whilst aspirin and indomethacin (cyclooxygenase inhibitors) have no 
effect on chemotaxis (Wildfeuer, 1983). Piroxicam (cyclooxygenase 
inhibitor) inhibits neutrophil aggregation (Edelson et al, 1982). 
Moreover piroxicam, indomethacin, flurbiprofen, ibuprofen, ketoprofen 
(cyclooxygenase inhibitors), benoxaprofen, eicosatetraynoic acid, (ETYA) 
(mixed cyclooxygenase/lipoxygenase inhibitors) and p-bromophenacyl 
bromide (pBPB)(phospholipase inhibitor) all inhibit degranulation 
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The evidence for whether or not * generation is affected by these 
agents is more contentious, with some workers claiming that NSAIDS 
such as benoxaprofen, diclofenac, aspirin and indomethacin have no 
effect (Wildfeuer, 1983; Spisani et al, 1984), whilst other labora­
tories claim that these same drugs along with other cyclooxygenase 
inhibitors such as phenylbutazone, mefenamic acid, flufenamic acid, 
piroxicam, ibuprofen and phospholipase inhibitor pBPB all inhibit
release (Oyanagui, 1976, 1978; Smolen and Weissmann, 1980; Edelson 
et al, 1982). The discrepancies in these results could be explained 
in terms of the wide range of concentrations of drugs used and the 
stimulus employed as well as the type and origin of the cells.
Certainly most of the concentrations used are too high to be relevant 
in vivo, especially as it must be remembered that effective plasma 
concentrations of NSAIDS are affected by plasma proteins and that 
normally at least 90% of the drug will be protein-bound, although 
protein-binding is reported to be lower in synovial fluid (Wanwimolruk,
Brooks and Birkett, 1983). The concentration in the plasma will
-7 -6normally be about 10 - 10 M, with benoxaprofen rather higher at
-410 M (Anderson et al, 1984). Thus, from Table 1.1, it can be seen
that none of the experiments showing inhibition of human phagocyte
cell function are performed at physiologically relevant concentrations,
except for Smith and Iden's work with benoxaprofen showing significant
-5inhibition of degranulation at 5 x 10 M (Smith and Iden, 1980).
Only Oyanagui (1976, 1978) has been able to show consistently that 
O^* release is inhibited by all NSAIDS he tested, but this is using 
guinea pig macrophages and a rather obscure assay method which employs 
NADH and lactate dehydrogenase. He did not use standard assays 
because they proved too insensitive and thus the amounts of O^• he was 
measuring must have been minute.
— 63 —
There are few published reports on the functions of neutrophils 
isolated from individuals following administration of NSAIDS. Anderson 
et al (1984) reports that coincubation of normal neutrophils with 
serum from individuals who had ingested benoxaprofen, 600mg daily for 
7 days, resulted in decreased cell migration (mean inhibition 44%). 
However, neutrophils from those individuals showed no effects of 
decreased migration. This was attributed to the washing of the drug 
off the neutrophils during cell processing. Ingestion of benoxaprofen 
was not associated with any detectable effects on phagocytosis or 
oxidative metabolism by neutrophils. Similarly Wildfeuer (1983) found 
that benoxaprofen did not significantly reduce the chemotactic locomotion 
of neutrophils or monocytes isolated from volunteers after repeated 
oral administration of the drug (600mg daily for 7 days). Abramson 
et al (1983) reported that, following ingestion of piroxicam daily for 
3 days, neutrophils from those individuals, stimulated with FMLP, 
showed decreased aggregation, release and degranulation. The 
responses of FMLP-stimulated neutrophils from subjects taking ibuprofen 
at 2400mg daily for 3 days showed inhibition of aggregation and degran­
ulation but there was no effect on superoxide generation.
The mechanism of action of these drugs in inhibiting neutrophil 
functions is not clear. Various suggestions have been put forward 
including inhibition of membrane calcium release (Edelson et al, 1982); 
blockage of membrane SH groups or NADPH oxidase (Oyanagui, 1978) and 
elevation of cyclic AMP (Higgs and Vane, 1983) . However the doses 
which tend to produce these effects are too high to be relevant in vivo. 
Moreover, it may be that some of these NSAIDS appear to be inhibiting 
neutrophil function merely by interfering with the binding of the 
stimulus to its receptor. Many.of these studies used FMLP to stimulate 
the neutrophils and yet it has been shown that piroxicam (Edelson et
— 6 4  —
al, 1982); indomethacin (Abita, 1981) and sulindac (Van Dyke et al,
1982) are ail capable of inhibiting binding of [^H] FMLP, Another 
suggestion is that these drugs may act as direct Og-derived free 
radical scavengers. It has been proposed that NSAIDS may act via the 
formation of complexes with copper in vivo which can catalytically 
eliminate superoxide radicals (Lengfelder, 1984) and indeed copper 
complexes of indomethacin following in vivo administration of the 
drug have been isolated. NSAIDS have been shown to inhibit synovial 
fluid degradation induced by free radicals generated enzymatically 
(Puig, Parellada and Planas, 1978) and it has also been shown that 
NSAIDS reduce the levels of free radical oxidation products in the 
serum and synovial fluid of patients with RA (Lunec et al, 1981). 
Moreover the inactivation of a bacteriophage by OH-radicals is strongly 
inhibited by the presence of NSAIDS. Pulse radiolysis shows that OH* 
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ROUTINE BUFFERS AND SOLUTIONS
Calcium and Magnesium Free Salt Solution (CMFSS)
Sodium Chloride 
Potassium Chloride 
Potassium Dihydrogen Phosphate 







The pH was adjusted to 7.3 with IM NaOH, then the buffer was aliquoted 
in 100ml quantities, autoclaved at 120®C for 20 minutes, and stored 
at 4°C. On the day of use, 0.160g of glucose was added to each 100ml 
quantity.













The pH was adjusted to 7.3 with IM NaOH. This solution was prepared 
immediately prior to use and not stored.
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Phosphate Buffer 0.0IM
Potassium Dihydrogen Phosphate 1.74g
Disodium Hydrogen Phosphate 1.78g
Distilled Water to 1000 ml
The pH was adjusted to 6.5 with IM NaOH. The buffer was prepared 
immediately prior to use and not stored.
Phosphate Buffered Saline (PBS)
This buffer was prepared from commercially available tablets, either 
as single strength (1 tablet in 100ml distilled water) or lOX strength 
(10 tablets in 100ml distilled water). When used in the preparation 
of Percoll it was first filter-sterilized using a millipore filter 
pore size 0.22nin.
Ammonium Chloride Solution 0.83% w/v 
Ammonium Chloride 0.083g
Distilled Water to 10 ml
This was used for the lysis of contaminating erythrocytes during 
neutrophil preparation. It was prepared immediately prior to use 
and not stored.
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SOURCE OF EXPERIMENTAL BLOOD AND PATIENT SELECTION
The majority of experiments and all control experiments were performed 
with cells obtained from the blood of normal healthy volunteers.
These volunteers were either staff and students of Bath Arthritis 
Research Centre or staff of the Royal National Hospital for Rheumatic 
Diseases (RNHRD), Bath.
Patients with progressive systemic sclerosis (PSS) were selected by 
Dr. Peter Maddison, Consultant Rheumatologist. Blood was obtained 
from age-and sex-matched patients with rheumatoid arthritis 
receiving a similar drug therapy to those with PSS. These were all 
in-patients from the wards of RNHRD.
Patients with peripheral vascular disease were identified by Dr. Tony 
Woolf, Senior Registrar, RNHRD. These were all patients of Mr. R. 
Turnball, Consultant Surgeon, and were in-patients at the Royal United 
Hospital, Bath.
Patients used in the non-steroidal anti-inflammatory drugs in vivo 
study were either early synovitis patients under the care of Dr. Tony 
Woolf, or else osteoarthritis patients under the care of Dr. Jane 
Calin.
All blood was obtained by venepuncture with informed consent.
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METHODS
1. PREPARATION OF CELLS
Cell separation was performed in round-bottomed polycarbonate 
centrifuge tubes to prevent activation of the neutrophils. These 
tubes, unlike those made of glass, do not promote adherence of 
neutrophils (Cook, Counter and McColley, 1976).
The colloidal silica sol coated with polyvinylpyrrolidone marketed 
as Percoll was used to separate cells by density-gradient centrifu­
gation (Pertoft, Back and Lindahl-Kiessling, 1968; Pertoft et al,
1977; Segal, Fortunate and Herd, 1980).
la) Preparation of Percoll
-1Percoll from Pharmacia has a density of 1.130 ±0.005g.ml . Nine
parts of this were mixed with one part of lOX PBS to give "100% Percoll"
This was then further diluted with single strength PBS to give the
appropriate densities for separating the required cell populations
from heparinized whole human peripheral blood. These were;
-177% v/v (density 1.097g.ml ) granulocytes
-165% v/v (density 1.083g.ml ) mononuclear cells
-I52% v/v (density 1.068g.ml ) monocytes
lb) Cell Separation
Cells were prepared from whole human peripheral blood, with heparin 
as the anti-coagulant at a concentration of 125U per 10ml of blood.
The blood was diluted X2 with CMFSS.
Gradients of Percoll were prepared by placing 2ml 77%v/v Percoll in 
the centrifuge tube and layering onto this, 1.6ml of 65%v/v Percoll.
This was accomplished with the aid of a 2ml syringe barrel fitted with 
a 21G needle, the syringe being clamped so that the tip of the needle 
just rested on the meniscus of the 77%v/v Percoll.
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The 65%v/v Percoll was then placed in the syringe with a pasteur 
pipette, and allowed to run onto the top of the 77%v/v Percoll. The 
diluted blood was then layered on top of the Percoll gradient using 
a bent pasteur pipette. The tubes were centrifuged at room temperature 
at 400g for 30 minutes.
This procedure resulted in 2 discrete bands of cells (Figure 2,1). 
Granulocytes were harvested from the 77%v/v/65%v/v Percoll interface 
and the mononuclear cells were harvested from the 65%v/v Percoll/plasma 
interface using pasteur pipettes. Granulocytes were washed in CMFSS 
by centrifugation at 250g for 10 minutes. Any contaminating
erythrocytes were then lysed by treatment with 0.83% w/v ammonium
chloride at 37°C for 10 minutes.
If monocytes were to be prepared, the mononuclear cells were suspended 
in CMFSS and layered on top of 2ml 52% v/v Percoll. The tubes were 
then centrifuged at room temperature at 750g for 30 minutes and the 
band of monocytes harvested from the surface of the 52% v/v Percoll.
Both cell populations were then washed twice in CMFSS by resuspension 
and pelleting at 250g for 10 minutes and the resultant pellets 
resuspended in 1ml of appropriate buffer for counting.
All cell counts were made using a Neubauer counting chamber. Cell 
suspensions were diluted in white cell counting fluid containing 3% 
acetic acid and 0.1% methylene blue. Cell viabilities were checked by 
the method of trypan blue exclusion.
Cells prepared in this way were always >95% pure and >99% viable. The
granulocytes were considered to contain a negligible number of eosinophils
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Figure 2.1 CELL SEPARATION
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2. PREPARATION OF STIMULI
During the course of these studies, three stimuli were employed. These 
were heat-aggregated IgG (HAGG); n-formyl-l-methionyl-l-leucyl-l-phenyl- 
alanine (FMLP) and opsonized zymosan.
2a) Heat-aggregated IgG 
Preparation of IgG
Ion-exchange chromatography with diethyl aminoethyl (DEAE) Sephadex 
was employed to prepare IgG in a modification of a method by Ishizaka 
(1965). 10ml of an IgG myeloma serum were dialysed overnight against 
lOmM phosphate buffer pH 6.5. DEAE-Sephadex was swollen in lOmM 
phosphate buffer pH 6.5 overnight. After filtration through a Buchner 
funnel, the cake of Sephadex was mixed with the serum to give a thick 
paste which was stirred for 1 hour at 4°C. It was then filtered again 
and washed with phosphate buffer. The filtrate was collected and 
the protein content determined by the Folin-Ciocalteau method of protein 
estimation (Lowry 1951). The IgG solution was aliquoted into 1ml 
quantities and stored at -20°C.
Immuno-electrophoresis
The components of the two batches of IgG solution prepared in this way 
were determined using immuno-electrophoresis. A third batch of IgG, 
which has been previously prepared in the laboratory, was also tested 
for comparison.
This technique was carried out using glass photographic plates coated 
with 2% w/v agar in barbitone buffer containing 0.1% w/v sodium azide.
A sample of each batch of IgG, together with a sample of human serum 
were applied to the plates which were then placed in a bath filled with 
sodium barbitone/acetate buffer pH 8.6. It was electrophoresed for 
approximately 3 hours at 10mA lOOV. Bromophenol blue was used as a 
migration indicator.
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After this time, anti-human IgG was added to the troughs of one plate 
and anti-whole human serum added to the troughs of the second plate. 
The plates were then placed in a humid container and incubated at room 
temperature overnight. The plates were then washed three times in 
0.9% w/v saline and, after drying, were stained with 0.1% w/v Ponceau 
S in 3% w/v trichloroacetic acid and destained in 5% v/v acetic acid. 
The plates were photocopied and the photocopy was traced (Figure 2.2).
Aggregation of IgG
Suitable aliquots of IgG were placed in a water bath at 63®C for 
30 minutes. At the end of this time, aggregates had formed which 
sedimented rapidly on standing. Aggregates were always formed just 
prior to each experiment and were never stored.
2b) n-Formyl-l-methionyl-l-leucyl-l-phenylalanine (FMLP) 
lOmg of FMLP were dissolved in 1ml dimethyl sulphoxide and adjusted 
to a final concentration of lOmM with CMFSS. This was stored at 
-70®C in 100|il aliquots and appropriate dilutions made with CMFSS as 
required.
2c) Opsonized Zymosan
40mg of Zymosan A were boiled for 30 minutes in 0.9% w/v saline +
2mM calcium chloride. The zymosan was washed once by centrifugation 
in 0.9% w/v saline + 2mM calcium chloride and the pellet resuspended 
in 8ml of fresh human serum. After incubation at 37°C for 30 minutes, 
the coated zymosan was washed twice with PBS and suspended at a final 
concentration of 40mg/ml in PBS. Boiled and washed, but otherwise 
untreated, zymosan A at an identical concentration in PBS was also 
prepared for comparative purposes. The opsonized zymosan was stored 
at -70°C for periods up to 14 days.
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WELL 1 : IgG Batch 1
WELL 2 : Laboratory stock IgG
WELL 3: IgG Batch 2
WELL 4 : Human Serum
Figure 2.2 IMMUNO-ELECTROPHORESIS PLATES
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3. ASSAYS FOR HYDROGEN PEROXIDE 
3a) OXIDATION OF PHENOL RED
This assay to determine levels of hydrogen peroxide generated by 
phagocytic cells was first described by Pick and Keisari (1980, 1981). 
The assay is based on the hydrogen peroxide - dependent, horseradish 
peroxidase - mediated oxidation of phenol red resulting in the 
appearance of a compound with an increased absorbance at 610nm at 
alkaline pH from that of native phenol red (Figure 2.3).
Standardization of Assay
First the phenol red assay was standardized by using hydrogen 
peroxide solutions in distilled water of known concentrations. To 
1ml aliquots of buffered phenol red solution in LP3 tubes, 10|al of 
appropriate dilutions of hydrogen peroxide were added to result in a 
range of final concentrations of hydrogen peroxide from l|iM - 100|iM. 
The tubes were incubated for 5 minutes at room temperature, lOp-l of 
3M NaOH added to raise the pH to 12.5 and the absorbance at 610nm read 
in the spectrophotometer against blanks containing 1ml buffered phenol 
red solution, lOpd 3M NaOH and 10|il hydrogen peroxide at the 
corresponding dilutions (added after the 3M NaOH). It was established 
that there was a linear relationship between absorbance at 610nm and 
hydrogen peroxide concentration in the l-60|iM range, corresponding to 
l-60nmoles hydrogen peroxide per ml. This procedure was repeated on 
several occasions and the results used to compute a 'line of best fit'. 
This was stored on disc so that accurate, reproducible determinations 
of concentrations from corresponding absorbance readings could be made 
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Figure 2.3 ABSORPTION SPECTRA OF NATIVE AND HgOg-OXIDIZED PHENOL 
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Figure 2.4 CURVE FOR STANDARDIZING THE PHENOL RED ASSAY,
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The Use of the Phenol Red Assay for the Quantitation of Hydrogen 
Peroxide Produced by Phagocytic Cells
Neutrophils or monocytes were suspended, after counting, in buffered 
phenol red solution at a final concentration of 1 x 10^/ml or 
2 X 10^/ml as appropriate. The cells were aliquoted in 1ml quantities 
into LP3 tubes, which already contained any appropriate stimulant, 
scavenger or inhibitor. The tubes were then incubated at 37°C for 
the appropriate length of time (usually 30 minutes). After this time 
the tubes were placed on ice for 5 minutes and then centrifuged at 
1500g for 5 minutes. The supernatants were then placed in fresh LP3 
tubes containing 10|il 3M NaOH, and the absorbance at 610nm read 
against corresponding blanks containing 1ml buffered phenol red 
solution, lOjil 3M NaOH and any appropriate stimulant, scavenger or 
inhibitor. Each incubation was performed in duplicate and each 
incubation was run in parallel with duplicates containing 1500 Units 
catalase. The purple-mauve colour produced on the addition of 3M 
NaOH was stable for several hours but the results were always read 
immediately.
3b) FERRITHIOCYANATE ASSAY
This assay was an adaptation of the method described by Thurman, Ley 
and Scholz (1972) , involving the production of a red-brown complex 
by ferrous ammonium sulphate and potassium ferrithiocyanate in the 
presence of hydrogen peroxide, under acidic conditions.
Standardization of Assay
To 900JJ.1 aliquots of CMFSS in LP3 tubes were added 10|il of appropriate 
dilutions of hydrogen peroxide in distilled water to result in a 
concentration range of 5-50|iM. To each tube was added lOOiil 
trichloroacetic acid 6M, 200|il ferrous ammonium sulphate lOmM and 
finally lOOjJ.1 potassium ferrithiocyanate 2.5M The absorbance at 480nm
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was read against a blank containing all those constituents except 
hydrogen peroxide, which was replaced with 10|il distilled water.
A linear relationship was established between the absorbance at 
480nm and hydrogen peroxide concentration in the 5-50|iM range, 
corresponding to 5-50nmoles hydrogen peroxide per ml. This 
procedure was repeated on several occasions and the results used to 
compute a 'line of best fit'. This was stored in the same way as that 
for the phenol red assay (Figure 2.5).
The Use of the Ferrithiocyanate Assay for the Quantitation of 
Hydrogen Peroxide Produced by Neutrophils
Neutrophils were suspended, after counting, in CMFSS at a concen­
tration of 2 X 10^/900^1. The cells were aliquoted in 900p,l 
quantities into LP3 tubes already containing any appropriate 
stimulant, scavenger or inhibitor. The tubes were then incubated at 
37°C for 30 minutes. After this time the tubes were placed on ice 
for 5 minutes, and then centrifuged at 1500g for 5 minutes. The 
supernatants were then placed in fresh LP3 tubes and 100|il trichloro­
acetic acid 6M were added to each tube, followed by 200|il ferrous 
ammonium sulphate lOmM and lOOiil potassium ferrithiocyanate 2.5M.
The absorbances at 480nm were read immediately against a blank which 
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Figure 2,5 CURVE FOR STANDARDIZING THE FERRITHIOCYANATE ASSAY,
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4. ASSAY FOR SUPEROXIDE ANION
The assay used was a modification of the micro-assay described by 
Pick and Mizel (1981) which utilizes the reduction of cytochrome C 
as the basis for the detection of superoxide anion. Incubations are 
performed in a flat-bottomed microwell plate and results read using 
an automatic plate reader which enables large amounts of data to be 
generated relatively quickly.
4a) Enzymatic Generation of Superoxide Anion
Superoxide anion was generated enzymatically using the xanthine/ 
xanthine oxidase system to test any effect the different drugs/ 
inhibitors might have on superoxide anion itself.
A saturated solution of xanthine was made in distilled water and left 
overnight. This was then filtered immediately prior to use and 
adjusted to pH 7 with IM NaOH. lOOp.1 were placed in each well of a 
96-well flat-bottomed microtitre plate. The wells already contained 
the appropriate concentrations of the drugs to be tested in lOjil 
quantities. Control wells contained IOm.1 solvent. Superoxide 
dismutase (50 Units in lOiil CMFSS) was added to certain other control 
wells. To all wells was added lOOfil cytochrome C solution in CMFSS 
such that the final concentration was ISO^xM. To start the reaction 
10|j.l xanthine oxidase (5 Units/0.3ml diluted 1 in 25 with CMFSS) was 
added to each well except the blank and to certain control wells 
containing just drug. The plate was incubated at room temperature 
for 10 minutes and then the absorbances at 550nm read using an 
automatic elisa plate reader.
Each incubation was performed in quadruplicate. The absorbance 
expressed was the difference between that produced in the absence 
of superoxide dismutase and that produced in its presence to give 
the increase in absorbance specific to superoxide.
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4b) Measurement of Superoxide Anion Production by Neutrophils 
A 96-well microtitre plate was prepared by placing in it appropriate 
stimuli at various concentrations. Each concentration of each stimuli 
was performed in quadruplicate. Control wells contained 50 Units 
superoxide dismutase. After counting, neutrophils were suspended in 
160|iM cytochrome C at a concentration of 1 x 10^/ml or 2 x 10^/ml. 
200|il aliquots (ie. 2 x 10^ or 4 x 10^ cells) were placed in the wells 
and the plate was incubated at 37®C for the appropriate length of time 
The absorbances at 550nm were read against a blank containing no cells 
using an automatic elisa plate reader. The absorbance expressed was 
the difference between that produced in the absence of superoxide 
dismutase and that produced in its presence to give the increase in 
absorbance specific to superoxide.
Calculation of Results
Results were expressed in terms of nmoles cytochrome C reduced using 
the formula:
A = Eel A = Absorbance
c = concentration (mM)
1 = length of light path (cm)
-1 -1E = Extinction coefficient = 21.ImM cm
1 was determined by measuring the radius (r) of the wells and then 
applying the formula:
Volume = Ilr^h
where h is the height of liquid in the well and therefore the length 
of the light path.
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5. OXYGEN CONSUMPTION
Oxygen uptake by neutrophils was measured using a Clark-type oxygen 
electrode maintained at 37°C. This electrode incorporated a magnetic 
stirrer and was used in conjunction with a potentiating and zero 
suppress unit and a chart recorder.
5a) Calibration of Electrode
The electrode was allowed to equilibrate with 2ml CMFSS at 37®C 
inside the reaction chamber. When a stable trace was attained 
(the "air line") a few crystals of sodium dithionite were added to 
the reaction chamber. The output dropped rapidly as the dithionite 
reacted with the dissolved oxygen. The new value attained at the 
lower output was known as the "N^ line". The difference between the 
air-line and the N^ line represents the oxygen concentration which, 
for 2ml CMFSS at 37°C is equal to 360nmoles oxygen (Hansatech literature) 
Once the electrode was calibrated in this way, the scale could be 
linearly expanded by altering the mV setting of the recorder to 
increase the sensitivity.
The reaction chamber was then washed several times with more CMFSS to 
remove all traces of dithionite.
5b) Oxygen Uptake by Neutrophils
After counting, neutrophils were suspended at a concentration of 
1 X  10^/900iil in CMFSS. 1.8ml of cell suspension was introduced into 
the reaction chamber and allowed to equilibrate until a steady trace 
was attained. Then 200nl of the appropriate stimulus was introduced 
into the reaction chamber through the plunger, by means of a micro­
syringe. With the chart recorder set at a known speed, the 
consumption of oxygen by the cells in response to the stimulus could
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be monitored over a set time period. The chamber was washed several 
times with CMFSS between each incubation.
In practice this method was not used as extensively as it had been 
hoped. Due to the length of equilibrating times, washing times and 
only one set of conditions prevailing at any one time, very few 
results could be gathered before the cells began to aggregate or die.
6. MEASUREMENT OF SERUM SULPHYDRYL LEVELS
Levels of serum sulphydryl (SH) groups can be measured using Ellmann's 
Reagent (DTNB 0.8mg/ml). Serum SH groups can be oxidized by hydrogen 
peroxide and consequently the lowered levels of residual SH groups 
can be determined by this method. (Hall, Blake and Bacon 1982; Hall, 
Maslen and Blake 1984).
6a) Oxidation of Serum SH Groups by Hydrogen Peroxide 
SH oxidation mediated by hydrogen peroxide was assessed by reacting 
50|J.l aliquots of serum with various concentrations of hydrogen peroxide 
diluted in CMFSS. Each mixture (700|il) was incubated at 37®C for 
30 minutes after which the reaction was terminated by the addition 
of 1500 Units catalase contained in 100|il CMFSS. SH levels were 
determined as outlined below.
6b) Oxidation of Serum SH by Hydrogen Peroxide Produced by Stimulated 
Neutrophils
Each incubation in LP3 tubes contained an appropriate number of 
neutrophils, 4mg heat-aggregated IgG and 100)il serum in a final volume 
of 2ml. Certain control incubations contained 1500 Units catalase.
The cells were incubated for 30 minutes at 37°C and the reaction 
terminated by the addition of catalase (1500 Units). The tubes were
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centrifuged for 5 minutes at 750g and residual serum SH levels were 
determined as outlined below.
6c) SH Assay
800jil of hydrogen peroxide + serum system or 800)il of cell supernatant 
were incubated with 200|il DTNB (0.8mg/ml in O.lM phosphate buffer pH 
7.4) for 5 minutes at 37°C. The cibsorbance at 440nm was then read 
against a blank containing CMFSS in place of the supernatant and DTNB. 
The reading obtained was converted to serum SH levels in pmol.l by 
reference to a calibration curve obtained using reduced glutathione 
in the assay system.
This assay was also used to determine the effects of drugs on levels 
of SH groups. In these cases, the incubations contained 50|il serum, 
lOjj.1 appropriate concentration of drug and 750)il CMFSS. After 
incubation at 37®C for 30 minutes, 2GÜM-1 DTNB (0.8mg/ml) were added 
and the procedure above followed.
7. BLOCKADE OF CELL SURFACE SULPHYDRYL GROUPS
Neutrophils and monocytes were separated as described. After one 
wash with CMFSS, the two cell populations were divided into half and 
one half of each cell population was incubated for 1 hour at 37®C with 
the irreversible, non-penetrating SH blocker parahydroxymercuriphenyl- 
sulphonic acid (pHMPSA) (Tsan and Berlin, 1971). All cells were then 
washed three times with CMFSS and, after counting, resuspended in 
buffered phenol red solution at a concentration of 1 x 10^/ml. The 
cells were then stimulated and levels of hydrogen peroxide produced 
were measured as described.
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8. EA ROSETTE ASSAY
8a) Preparation of Antibody by Affinity Chromatography 
The IgG fraction used to sensitize calf erythrocytes was prepared from 
a rabbit anti-calf erythrocyte antiserum by affinity chromatography 
on a protein A-Sepharose CL-4B column. Protein A binds the Fc portion 
of IgG (1,2,4) at neutral pH. This interaction is disrupted at low 
pH and hence the IgG can be recovered using acetic acid. This 
procedure was based on the method of Hjelm and Hjelm as used by 
Hall (Hall, 1978).
The protein A-Sepharose CL-4B column was washed with PBS for 10 
minutes and then 2ml of rabbit antiserum was added to the column.
This was washed through with PBS until the first protein fraction 
was eluted. This was discarded. IM acetic acid was then added to the 
column and the IgG fraction collected on ice in a fresh container.
The IgG fraction was concentrated to approximately 10ml using a 
positive pressure Amicon unit fitted with a PM50 membrane. The 
concentration of the protein solution was estimated by measuring its 
absorbance at 280nm and 260nm and by reference to a nomogram. The IgG 
solution was dialysed against PBS at 4®C for 4 hours, with a change 
of PBS after 2 hours. The IgG was stored at -20°C in 200)il aliquots 
and thawed only once before use.
8b) Detection of Neutrophil Fc Receptors
Calf erythrocytes in Alsevers solution were washed three times with 
CMFSS. They were then resuspended at 2% v/v in CMFSS and sensitized 
by incubation with an equal volume of appropriate dilutions of the 
prepared antibody at 37°C for 30 minutes. The erythrocytes were then 
washed three times in CMFSS and resuspended in CMFSS at 1% v/v.
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Neutrophils were prepared as previously described and resuspended at 
a concentration of 2 x 10^/ml in CMFSS. 200|-il of neutrophil suspension 
were mixed with 200^1 of each sensitized erythrocyte suspension in 
LP4 tubes. The tubes were then centrifuged at llOg for 3 minutes and 
incubated on ice at 4°C for one hour. The pellets were then 
resuspended on a rotating turntable (20 rpm) for 30 seconds. 50pl of 
a saturated solution of methyl violet in CMFSS was added to each tube 
and the number of rosette-forming cells counted using a haemacytometer. 
A rosette was defined as 3 or more erythrocytes in contact with a 
neutrophil. At least 100 neutrophils were counted and the percentage 
of those which had formed rosettes calculated.
9. STATISTICAL ANALYSIS
Unless otherwise stated, statistical significance was tested for by 
the Mann-Whitney U test for non-parametric data. Correlation 
coefficients were obtained from the Spearman's Rank Correlation 
Coefficient for non-parametric data. All statistical methods were 
performed using the statistics software package supplied with the 




R E S U L T S
MEASUREMENT OF THE RESPIRATORY BURST OF PHAGOCYTIC CELLS
There are several techniques available for evaluating the respiratory 
burst of phagocytic cells. Oxygen uptake may be measured; the 
generation of oxygen-derived free radicals Og', ^2^2 OH*can be 
assessed using a variety of assays; or the increase in glucose 
oxidation via the BMP shunt can be measured. Although the majority of 
work in this thesis employed assays for HgOg, both oxygen consumption 
and superoxide generation were briefly examined,
3a) Oxygen Consumption
Experiments were performed using 2 x 10^ neutrophils isolated from 
healthy volunteers in 2ml CMFSS at 37°C, HAGG at various concentrations 
was added after equilibration and oxygen consumption monitored over 
10 minutes using the oxygen electrode as described in Chapter 2, The 
results for the amount of oxygen consumed in 10 minutes in response to 
various concentrations of HAGG are shown in Figure 3,1 and a typical 
kinetic study is shown in Figure 3,2, This demonstrates that, following 
a lag period of approximately 20 seconds, 50% of the response occurs 
after 1 minute and after 4 minutes, 95% of the response is complete. 
Unfortunately it became apparent that this method of monitoring the 
respiratory burst was not very practical. Cells began to aggregate and 
die in the stock solution before many experiments could be performed and 
so it was decided not to continue with this technique,
3b) Superoxide Generation
4 X 10^ neutrophils from healthy volunteers were stimulated with HAGG 
or FMLP at various concentrations in the presence of cytochrome C in 











Figure 3.1 Oxygen consumption by human neutrophils stimulated 






of cells of HAGG
Figure 3.2 Kinetics of 0^ consumption over 10 minutes by 2 x 10 
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Figure 3.3 Reduction of cytochrome C by stimulated neutrophils after 
30 minutes (superoxide specific). Results presented as 
X ± SD of 4 experiments. A:Dose response to HAGG;
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Figure 3.4 Reduction of cytochrome C by neutrophils stimulated by HAGG 
(superoxide specific). Results presented as X ± SD of 4 
experiments. A:Time course using lOOpg/ml HAGG; BzTime 
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Figure 3.5 Reduction of cytochrome C by neutrophils stimulated by
FMLP (superoxide specific). Results presented as X ± SD 
of 4 experiments. ArTime course using FMLP lOpM;
BzTime course using FMLP 25|iM; CzTime course using FMLP 
50m m .
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are shown in Figures 3.3 - 3.5. Results are expressed in terms of 
nmoles of reduced cytochrome C/2 x 10^ cells. This reduction is 
superoxide specific i.e. reduction in the absence of superoxide dismu- 
tase minus that in its presence. It also takes into account any 
background release by unstimulated cells. It appears that the higher 
the concentration of HAGG used the less superoxide is generated and 
that also the lower concentration of HAGG (lOOiig/ml) stimulates a 
steady increase in the generation of superoxide whereas the higher 
concentration of HAGG (500|ig/ml) stimulates an initial generation of 
superoxide which reduces in rate after 5 minutes.
The concentrations of FMLP chosen (IO^lM, 25hM, 50|iM) appear to 
stimulate about the same amount of and similar rates of superoxide 
generation. The time courses for all concentrations show a reduction 
in rate of generation after 10 minutes.
3c) Peroxide Generation
2 X 10^ neutrophils from healthy volunteers were incubated with various 
concentrations of HAGG, FMLP or opsonized zymosan in 1ml incubations in 
the presence of phenol red and horseradish peroxidase at 37®C. The 
resulting oxidation of phenol red was expressed in terms of nmoles 
peroxide as described in Chapter 2.
The results of dose response and time courses are shown in Figures
3.6 - 3.8. All results are corrected for background release.
The results show a dose - and time-dependent generation of peroxide in 
response to each stimulus. It can be seen that 50% of the maximum
response by 2 x 10^ neutrophils is reached after approximately 4
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Figure 3.6 Peroxide production by human neutrophils stimulated by
HAGG. ^Results expressed as nmol peroxide produced/
2 X 10 cells_(corrected for background release) and 
presented as X ± SD of 3 experiments. AzDose response 



















Figure 3.7 Peroxide production by human neutrophils stimulated by 
FMLP. ^Results expressed as nmol peroxide produced/
2 X 10 cells_(corrected for background release) and 
presented as X ± SD of 3 experiments. A;Oose response 
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Figure 3.8 Peroxide production by human neutrophils stimulated by 
opsonized zymosag. Results expressed as nmol peroxide 
produced/ 2 x 10 _cells (corrected for background release) 
and presented as X ± SD of 4 experiments. AzDose response 
after 30 minutes; BzTime course using 800fig/ml opsonized 
zymosan.
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following stimulation with 20)iM FMLP and after about 20 minutes following 
stimulation with 800|ig/ml opsonized zymosan.
As more experiments with these stimuli were performed in the presence 
and absence of catalase, it quickly became apparent that, according to 
the stimulus used, not all the oxidation of phenol red could be 
prevented by this enzyme. Thus it was concluded that not all the 
oxidation of phenol red was due to hydrogen peroxide (Figure 3.9).
These results demonstrate that phenol red oxidation caused by unstimu­
lated or 'resting' cells is 97 ± 6% sensitive to catalase, i.e. it is 
due almost entirely to hydrogen peroxide. Similarly, cells stimulated 
by FMLP produce mainly hydrogen peroxide as 93 ± 9% of the oxidation 
can be inhibited by catalase. However, following stimulation by HAGG, 
only 23 ± 17% of the phenol red oxidation was inhibited by catalase and 
the equivalent figure following stimulation by opsonized zymosan was 
even lower, only 11 ± 9%. Thus cells stimulated by HAGG and opsonized 
zymosan at these concentrations produce some hydrogen peroxide but 
mainly another substance which is capable of oxidizing phenol red.
To ensure that sufficient catalase was present to break down any 
hydrogen peroxide produced various concentrations were added to 1ml 
aliquots of buffered phenol red solution. To this were added 20 nmoles 
of hydrogen peroxide and this was then incubated at 37®C for 10 minutes. 
The results are shown in Table 3.1. The routine concentration of 
catalase used, 1500 Units/ml, is clearly sufficient to break down any 
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8 0 0  f̂ g/ml
Figure 3.9 % Inhibition by catglase (1500 Units) pf phenol red
oxidation by 2 x 10 neutrophils in response to 
£timuli and by the cells alone. Results presented 
X ± SD of 10 experiments.
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Table 3.1 Absorbance readings at 610nm for phenol red solutions
containing 20 nmoles in the presence and absence of catalase.
Each experiment was set up in duplicate.
- 103 -
Reference to the original paper describing this assay (Pick and Keisari, 
1981) showed that they too could not abolish totally the oxidation of 
phenol red by the addition of catalase. They suggested that this may 
be due to competition between horseradish peroxidase and catalase for 
hydrogen peroxide. To investigate this a dose response to catalase 
was performed in the presence of 2 x 10^ neutrophils stimulated by 
200|ig HAGG. The results are shown in Figure 3.10. As there is very 
little difference in the catalase insensitive portion of phenol red 
oxidation regardless of the concentration of catalase used, it would 
seem unlikely that competition between horseradish peroxidase and 
catalase for hydrogen peroxide is the explanation for these observations 
The failure of catalase to suppress all phenol red oxidation under 
some circumstances could be due to the HAGG and opsonized zymosan 
binding to or inactivating the enzyme. Thus an assay for catalase was 
performed in the presence of these stimuli. 0.1ml 30% hydrogen 
peroxide was added to 50ml 0.05M phosphate buffer pH7. A solution of 
50 Units/ml catalase in 0.05M phosphate buffer pH7 was also prepared. 
0.1ml of this solution was added to 2.9ml of the hydrogen peroxide 
solution in a cuvette and the absorbance at 240nm read. The time 
required for the absorbance to decrease from 0.450 to 0.400 was noted. 
This corresponds to the decomposition of 3.45)jmoles hydrogen peroxide. 
This was then repeated in the presence of each stimulus in turn. If 
they were binding or inactivating the catalase then the time taken 
for the absorbance to drop would be considerably lengthened. The 
results in Table 3.2 show that this is not the case and thus the 
stimuli cannot be directly interfering with the ability of catalase to 
break down hydrogen peroxide.
To check that the catalase insensitive portion of phenol red oxida­
tion was not due to an intra-cellular source of hydrogen peroxide 
produced in response to HAGG and opsonized zymosan but not FMLP,
— 10 4  —
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Figure 3.10 Oxidized phenol red produced by 2 x 10 neutrophils
stimulated by 200|j.g HAGG in the presence of increasing 
concentrations of catalase.
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Time taken for absorbance at 240nm to drop 
from 0.450 to 0.400 (seconds);
X ±SD 
n=5
No stimulus 42 ± 3
+ lOOpg HAGG 48 ± 8
+ 400|ig opsonized zymosan 49 ± 7
Table 3.2. The time taken for 5 Units of catalase to decompose 3.45 
limoles HgOg in the presence and absence of HAGG (100|ig) and opsonized 
zymosan (400|J.g) .
nmoles oxidized phenol red/2xl0 /30 mins.Incubation
+ HRPO HRPO
Resting cells
Cells + 200|ig HAGG
Cells + FMLP (20|iM)
Cells + 800|ig opsonized 
zymosan
Table 3.3. Oxidized phenol red as a result of stimulation of 2x10 
neutrophils in the presence and absence of horseradish peroxidase.
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experiments were performed where cells were incubated with the stimuli 
as normal but were then disrupted with alkali and then removed by 
centrifugation before measuring the absorbance. Parallel incubations 
had cells removed by centrifugation and the supernatants treated with 
alkali. There was no difference in the ab.sorbance readings obtained 
using either method (results not shown).
The assay was also performed with neutrophils stimulated by all three 
stimuli in the presence and absence of horseradish peroxidase. The 
results in Table 3.3 show that omission of peroxidase results in total 
abolition of any oxidation of phenol red. Thus this indicates that 
whatever this other agent that is capable of oxidizing phenol red might 
be, it must be a peroxide and is henceforth referred to as ROOH.
To determine whether ROOH is produced at the same rate as any hydrogen 
peroxide generated in response to a stimulus by neutrophils, a time 
course was performed following the stimulation of HAGG in the presence 
and absence of catalase. The results were corrected for any background 
release of hydrogen peroxide and are shown in Figure 3.11. This 
demonstrates that there is a lag period associated with the release of 
ROOH but following that, release progresses at much the same rate as 
the rate of release of hydrogen peroxide. However, virtually all the 
hydrogen peroxide production is complete within 10 minutes whereas 
release of ROOH continues at much the same rate for at least 30 minutes. 
The ability of different concentrations of HAGG to promote the release 
of HgOg + ROOH was also assessed. These data are presented in Figure 
3.12 and show that at low concentrations of HAGG, virtually all the 
phenol red oxidation is due to hydrogen peroxide whereas at high 
concentrations, it is largely due to ROOH. Figure 3.13 shows the 
absolute amounts of hydrogen peroxide and ROOH produced in response to 
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Figure 3.11 Oxidized phenol red in response to 2 x 10 neutrophils 
stimulated with 200pg HAGG over 30 minutes (n=2).
Oxidation due to
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Figure 3.12 % total phenol red oxidation due to #  ROOH and^^H O
6following stimulation of 2 x 10 neutrophils by various 
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Figure 3.13 Absolute amounts of oxidized phenol red dug to #  ROOH
and^^H^O^ following stimulation of 2 x 10 neutrophils 
by various concentrations of HAGG for 30 minutes at 37°C,
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production increases with increasing HAGG concentrations, hydrogen 
peroxide production remains the same, is maximal at the lowest 
concentrations of HAGG and decreases at higher concentrations.
3d) Oxidation of Serum Sulphydryl Groups by H^O^ Released by 
Stimulated Neutrophils
Serum SH levels are depressed in patients with RA (Lorber et al, 1964). 
This depression is due to oxidation and subsequent mixed disulphide 
formation with cysteine of SH groups in albumin (Thomas and Evans, 1975) 
This SH oxidation could be mediated by hydrogen peroxide and to test 
this hypothesis this reagent was tested directly in the serum SH assay 
described in the previous chapter.
The results shown in Figure 3.14 show that hydrogen peroxide oxidises 
serum SH groups in a dose-dependent manner. Thus it may be calculated 
that oxidation of 25% of the serum SH groups in this assay system 
requires the presence of 300-400nmoles HgOg. From Figure 3.6 it can 
be seen that in vitro 2 x 10^ neutrophils can secrete 24 ± 3nmoles 
in response to 200pq HAGG. Thus approximately 30 x 10^ cells would 
have to be stimulated in order to demonstrate 25% serum SH oxidation 
by HgOg released by those cells. Data from three such large-scale 
experiments are shown in Table 3.4. The results obtained show very 
close agreement with the degree of serum SH oxidation predicted and 
complete protection of the serum SH groups was afforded by the 
presence of catalase in the assay system.
Since the results of this work has been published (Hall, Maslen and 
Blake, 1984) it has been realised that in fact 2 x 10^ neutrophils 
do not secrete 24nmoles HgOg, but probably more like 6nmoles, so the 
calculation that 30 x 10^ cells would produce 300-400nmol.es HgOg is
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Figure 3.14 Serum SH oxidation by HgOg.
% serum SH levels relative to values in untreated
samples (= 100%). 
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Results expressed as 
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30 73 73 86
25 78 83 108
32 71 71 99
Mean ± SD 76 ± 5 98 ± 9
Table 3.4 Serum SH oxidation by products of human neutrophils 
stimulated with heat-aggregated IgG. Each experiment was set up in 
duplicate with cultures containing neutrophils, 4mg heat-aggregated 
IgG and lOOjil serum in a final volume of 2ml. Catalase (1500 Units) 
was added to certain tubes as indicated. All incubations were carried 









Concentration Neutrophils /  ml
Figure 3.15 % total phenol red oxidation due to in response
to stimulation by 200|ig HAGG of increasing concentrations
of neutrophils, 
experiments.
Results presented as X ± SD of 10
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incorrect. However, this presumes a linear relationship between the 
number of neutrophils and the amount of secreted. During the
course of this work, using different concentrations of cells, it has 
become apparent that this is not so. The more cells that are stimu­
lated the proportionally more HgOg is released, and Figure 3.15 
demonstrates this. Although it is impossible to measure the amount 
of hydrogen peroxide produced by 30 x 10^ cells using the phenol red 
assay, due to the sensitivity of the assay, it would seem that by 
extrapolating Figure 3.15, large numbers of neutrophils, when 
stimulated with HAGG, produce a higher proportion of HgOg than ROOH.
3e) Release of Hydrogen Peroxide From Stimulated Monocytes
Human monocytes were incubated in the phenol red assay with HAGG 
(200p.g/ml) , FMLP (20|iM) or opsonized zymosan (SOOpg/ml) at a concen­
tration of 1 X 10^/ml. Hydrogen peroxide and ROOH release was 
measured over 30 minutes at 37®C in the presence and absence of 
catalase. A concentration of 1 x 10^/ml was chosen because of the 
lower yields of monocytes compared with neutrophils obtained from 
human blood.
The results shown in Figure 3.16 demonstrate the much lower levels of 
hydrogen peroxide (and ROOH) secreted by these cells compared with 
neutrophils. This is in agreement with work published by Johnston Jr., 
Lehmeyer and Guthrie (1976); Sagone Jr., King and Metz (1976) and Reiss 
and Roos (1978). However, Figure 3.17 shows that the proportion of 
hydrogen peroxide released compared with ROOH is higher from monocytes 
than neutrophils. The figures are 7% for neutrophils (1 x 10^/ml) and 
62% for monocytes (1 x 10^/ml) in response to HAGG (200jig/ml). It also 
seems likely that the proportion of hydrogen peroxide released is greater 
from monocytes stimulated with opsonized zymosan (BOOiig/ml) as 1 x 10^/ml














Figure 3.16 H O  and ROOH release by 1 x 10 monocytes over 30 minutes 





3 ROOH HAGG 200|ig
4 H2O2 FMLP 20|iM
5 H2°2 Opsonized Zymosan 800|J.g
6 ROOH Opsonized Zymosan 800|ig
Results are expressed X ± SD of 15 experiments.
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Resting HAGG FMLP Opsonized 
Cells 200  /tg ml 2 0 /tM Zymosan
Figure 3.17 % of pgenol red oxidation due to H O  secretion by 
1 X  10 monocytes in response_to stimuli and by cells 
alone. Results presented as X ± SD of 15 experiments
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monocytes generate 25% hydrogen peroxide and 2 x 10^/ml neutrophils 
generate 11% hydrogen peroxide. As is the case with neutrophils, 
unstimulated monocytes and monocytes stimulated by FMLP (20|iM) 
produce only hydrogen peroxide and not ROOH.
1 1 8  -
CHAPTER FOUR
RESULTS B
4. THE EFFECTS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND
OTHER INHIBITORS OF ARACHIDONIC ACID METABOLISM ON NEUTROPHIL 
OXIDATIVE METABOLISM
The ability of stimulated neutrophils to produce and ROOH was
examined in the presence of various inhibitors of arachidonic acid 
metabolism using the phenol red assay.
Before the inhibitors were incubated with the cells they were first 
tested in the assay to determine whether or not they had any direct 
effect on phenol red oxidation which would produce artefactual 
inhibitory results. This was achieved by incubating buffered phenol 
red solution with the inhibitors in the presence of a known amount of 
HgOg at 37°C for 30 minutes. Once any direct effects had been 
established, a range of concentrations of each inhibitor were incubated 
with cells at a concentration of 2 x 10^/ml in the presence of HAGG 
or FMLP and in the presence or absence of catalase at 37°C for 30 
minutes. Cell viability was checked at the end of the incubation 
period by trypan blue exclusion.
4.1.1 Cyclooxygenase Inhibitors
The results for cyclooxygenase inhibitors are shown in Figures 4.1 - 
4.5 and are expressed as % inhibition of the phenol red oxidation 
observed for 2 x 10^ stimulated cells alone and in the absence of
-4drug or catalase. The inhibitors used were indomethacin (2.8 x 10 M
“6 “4- 2.8 X 10 M); diclofenac sodium (6 x 10 M - 6 x 10 M); fenclofenac
(3 X  10 ^M - 3 X  10 ^M) and piroxicam (10 ^M - 5 x 10 ^M).
Indomethacin (Figure 4.1) had no direct effect on the phenol red assay 
and no effect on cell viability at the concentrations tested. This 
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Figure 4.1 Phenol red oxidation by 2 x 10 neutrophils stimulated 
by 200p.g HAGG: % inhibition in the presence of
indomethacin.
#  Stimulated cells + drug
O stimulated cells + drug + catalase
Bar Stimulated cells + catalase
Results expressed as X ± SD of 3 experiments
Incubation was for 30 minutes at 37°C.
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-4with 30% inhibition achieved at a concentration of 2.8 x 10 M,
“6falling to only 2% at 2.8 x 10 M.
Diclofenac sodium (Figures 4.2 - 4.3) had no effect on cell viability 
at the concentrations tested. However it had a direct dose-dependent
inhibitory effect on phenol red oxidation as shown, causing 90%
-4 -6inhibition at a concentration of 6 x 10 M, falling to 9% at 6 x 10 M
-7and 0% at 6 X 10 M. In spite of this, the drug still showed a dose-
dependent inhibition of phenol red oxidation by neutrophils in response
to stimulation by HAGG. Taking into account the direct effect on the
-5assay by the drug this inhibition is approximately 40% at 6 x 10 M,
"6 “730% at 6 X 10 M and 18% at 6 x 10 M. Thus diclofenac sodium is
more potent than indomethacin at inhibiting phenol red oxidation by 
neutrophils in response to stimulation by HAGG.
However, the results shown for the effect on HAGG-stimulated monocyte 
phenol red oxidation indicate that the drug had little if any effect 
on these cells. Catalase inhibits a higher proportion of phenol red 
oxidation caused by HAGG-stimulated monocytes than by neutrophils 
stimulated with HAGG i.e. monocytes release a higher proportion (but not 
absolute amount) of HgOg in response to stimulation than do neutrophils. 
This confirms results shown in Chapter 3.
Diclofenac sodium also showed a dose-dependent inhibition of phenol 
red oxidation by neutrophils stimulated by FMLP. This parallels the
effect on HAGG-stimulated phenol red oxidation, achieving 35% inhibition
—R **6 “7at 6 X 10 M, 35% at 6 x 10 M and 23% at 6 x 10 M, taking into
account the direct effect on the assay. However, unlike that stimu­
lated by HAGG, this oxidation is all catalase-sensitive i.e. it is 
all due to HgOg (Figure 4.3).
Fenclofenac (Figure 4.4) had no direct effect on the assay over the 
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Phenol re^ oxidation by A: 2 x 10^ neutrophils;
B: 1 X  10 monocytes stimulated by 200|j,g HAGG:
% inhibition in the presence of diclofenac sodium.
®  Stimulated cells + drugO Stimulated cells + drug + catalase
Direct effect of drug on assay 
Bar Stimulated cells + catalase
Results expressed as X ± SD of 3 experiments 
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Figure 4.3 Phenol red oxidation by 2 x 10 neutrophils stimulated 
by FMLP (20(iM) : % inhibition in the presence of
diclofenac sodium.
#  Stimulated cells + drug
O stimulated cells + drug + catalase
Direct effect of drug on assay
Bar Stimulated cells + catalase
Results expressed as X ± SD of 3 experiments 
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B
Figure 4.4 Phenol red oxidation by 2 x 10 neutrophils stimulated 
by A: 200|ig HAGG; B: FMLP (2ÜM.M) : % inhibition in the
presence of fenclofenac.
#  Stimulated cells O stimulated cells 





Results expressed as X ± SD of 4 experiments. 
Incubation was for 30 minutes at 37°C.
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—4concentration of 3 x 10 M. Fenclofenac shows a dose-dependent
inhibition of phenol red oxidation by neutrophils stimulated by HAGG,
-4achieving 35% inhibition at a concentration of 3 x 10 M (taking into
-6account cell death), falling to 14% at 3 x 10 M. This drug also
inhibits FMLP-stimulated phenol red oxidation by neutrophils,
“"4 — Aachieving 25% inhibition at 3 x 10 M and 20% at 3 x 10 M. Thus,
whilst fenclofenac is more potent than indomethacin, it is less potent
than diclofenac sodium at inhibiting phenol red oxidation by stimulated
neutrophils.
Piroxicam (Figure 4.5) had no direct effect on the assay over the
-4concentration range tested, but at 10 M it did cause 5% cell death.
Inhibition of phenol red oxidation by neutrophils stimulated by HAGG
-4is slight, with 29% inhibition achieved at 10 M. Moreover, inhibition
by this drug of phenol red oxidation by FMLP-stimulated neutrophils,
is also very slight and is not dose-related, with 24% inhibition 
-4achieved at 10 M.
A new cyclooxygenase inhibitor, pirprofen, a propionic acid derivative, 
was also tested in the assay system, but proved to interfere directly 
with the phenol red assay and so was not used with cells. As Table 
4.1 shows, pirprofen itself prevents phenol red oxidation by HgOg,
-3giving an apparent inhibition of phenol red oxidation of 97% at 10 M
—6and becoming negligible at 5 x 10 M.
4.1.2 Lipoxygenase Inhibitors
Nordihydroguaiaretic acid (NDGA) (Figure 4.6) has marked anti-oxidant 
properties at high concentrations and thus proved to have a direct
-6effect on phenol red oxidation, achieving 30% inhibition at 5 x 10 M


































10"^ 5X1(1® 10”®5X1()’6  10"® 5X1(5'^ 0
Concentration Piroxicam (M)
Figure 4.5 Phenol red oxidation by 2 x 10 neutrophils stimulated by 
A: 200|ig HAGG; B: FMLP (20|iM): % inhibition in the
presence of piroxicam.
®  Stimulated cells + drug 
Q  Stimulated cells + drug + catalase 
A  % cell death 
Bar Stimulated cells_+ catalase 
Results expressed as X ± SD of 3 experiments.
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5 X 10-4 0.010 98
10-4 0.150 76
5 X  IQ-3 0.257 42
10-5 0.307 31
5 X  10 0.450 0
10-G 0.465 0
Table 4.1 The direct effect of various concentrations of pirprofen 
on the phenol red assay. Each incubation was set up in 
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Figure 4.6 Phenol red oxidation by 2 x 10 neutrophils stimulated 
by A: 200|J.g HAGG; B: FMLP (20|iM) ; % inhibition in the
presence of NDGA.
o stimulated cells + drug Stimulated cells + drug + catalase
^  Direct effect of drug on assay 
Z a  % cell death 
Bar Stimulated cells_+ catalase 
Results expressed as X ± SD of 4 experiments. 
Incubation was for 30 minutes at 37°C.
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However, NDGA showed a dose-dependent inhibition of phenol red
oxidation by neutrophils stimulated by HAGG, with an inhibitory
-6 -7effect of 85% at 2 x 10 M and 23% at 10 M, taking into account the
direct effect on the assay. Moreover, it also showed an inhibitory
effect on FMLP-stimulated neutrophil-mediated phenol red oxidation
-6 -7achieving again 85% inhibition at 2 x 10 M and 36% at 10 M. Thus,
NDGA is much more potent than any of the cyclooxygenase inhibitors at 
inhibiting phenol red oxidation by stimulated neutrophils.
4.1.3 Cyclooxygenase/Lipoxygenase Inhibitors
Benoxaprofen (Figure 4.7) proved to have no direct effect on phenol
red oxidation over the concentration range tested, but did cause 10%
-3cell death at 10 M. Whilst it did show a dose-dependent inhibition of
phenol red oxidation by HAGG-stimulated neutrophils, its effect was
-3not very potent, with an inhibition of 67% at 10 M which fell rapidly 
to 10% at 10 ^M.
BW 755c (Figure 4.8) had a marked direct effect on phenol red oxidation,
with 100% inhibition at 10 ^M. However, this fell to 30% at 5 x 10 ^M 
-6and 3% at 10 M, and at these concentrations it caused an inhibition
of phenol red oxidation by HAGG-stimulated neutrophils of 34% at
"6 —05 X  10 M and 20% at 10 M. This was above that caused by a direct
effect on the assay. It did not have any effect on cell viability at
the concentrations tested.
4.1.4 Phospholipase A  ̂ Inhibitors
Quinacrine (Figure 4.9) could only be used over a narrow range of
—4 ""6concentrations (10 M - 5 x 10 M) as it proved to directly affect
phenol red oxidation at higher concentrations. It caused 30% cell
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Concentration Benoxaprofen (M)
Figure 4.7 Phenol red oxidation by 2 x 10 neutrophils stimulated 
by 200M.g HAGG: % inhibition in the presence of
benoxaprofen.
®  Stimulated cells + drug 
O  Stimulated cells + drug + catalase 
% cell death 
Bar Stimulated cells + catalase
Results expressed as X ± SD of 3 experiments. 
















10“̂ 5X10® 1C)® 5X10® 10"® 0
Concentration BW 755C (M)
Figure 4.8 Phenol red oxidation by 2 x 10 neutrophils stimulated 
by 200|j.g HAGG: % inhibition in the presence of BW 755C,
O
Stimulated cells + drug
Stimulated cells + drug + catalase 
Direct effect of drug on assay 
Stimulated cells + catalase
Results expressed as X ± SD of 3 experiments. 




















lO '^sxlO"^ 10® 5X10® 0
Concentration Quinacrine { M )
Figure 4.9 Phenol red oxidation by 2 x 10 neutrophils stimulated 
by 200hg HAGG: % inhibition in the presence of
quinacrine
#  Stimulated cells + drug 
O  stimulated cells + drug + catalase 
% cell death 
Bar Stimulated cells + catalase
Results expressed as X ± SD of 3 experiments. 
Incubation was for 30 minutes at 37°C.
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Correcting for this, the drug inhibited phenol red oxidation by HAGG-
stimulated neutrophils by 50% at 10 M, falling to 10% at 10 M and
-6with no effect at 5 x 10 M. It thus proved to be not very potent.
p-Bromophenacyl bromide (pBPB) had no direct effect on the assay and
-5only caused 5% cell death at a concentration of 5 x 10 M. It showed
a potent dose-dependent inhibition of phenol red oxidation by
-5neutrophils stimulated by HAGG, with 100% inhibition at 10 M and
-722% inhibition at 5 x 10 M. Similarly it had a marked inhibitory 
effect on phenol red oxidation by FMLP-stimulated neutrophils, 
achieving 100% inhibition at 10 and 46% inhibition at 5 x 10 ^M, 
(Figure 4.10).
4.1.5 Sulphydryl Group Blocker
The effects of the SH group blocker p-hydroxymercuriphenylsulphonic 
acid (pHMPSA) on the production of and ROOH by 1 x 10^
neutrophils and 1 x 10^ monocytes were also investigated. After 
pretreatment of cells with 50|iM pHMPSA for 1 hour at 37 ®C, production 
of both HgOg and ROOH by neutrophils and monocytes in response to 
stimulation by HAGG, FMLP or opsonized zymosan was completely inhibited 
(Table 4.2) . There was no effect on cell viability.
In addition, a dose-response experiment was performed using pHMPSA 
over a concentration range of l)iM - 50|iM. After pretreatment, cells 
were stimulated with HAGG in parallel with untreated cells (Figure 4.11) 
Unfortunately this experiment was not performed in the presence of 
catalase, so the effects on the production of HgOg and ROOH cannot be 
evaluated separately. However, a dose-dependent inhibition of phenol 
red oxidation could be observed, with total inhibition at 25|iM and an 
ID^q of 5jiM.
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5X10"® 1 0 ®  5 X 1 0 6  1 0 6 5 x 10 ^ 0
Concentration pBPB (M)
Phenol red oxidation by 2 x 10 neutrophils stimulated 
by A: 200|ig HAGG; B: FMLP (20|uM) : % inhibition in the
presence of pBPB.
e
O Stimulated cells + drug Stimulated cells + drug + catalase 
^  % cell death 
Bar Stimulated cells + catalase
Results expressed as X ± SD of 3 experiments. 
Incubation was for 30 minutes at 37°C.
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Table 4.2: The effect of pre-treatment of 1 x 10 neutrophils and 
monocytes by 50|iM pHMPSA for 1 hour at 37°C on 








1 10 25  50
Concentration pHMPSA { n M )
Figure 4.11 Oxidation of phenol red by 1 x 10 neutrophils 
stimulated by 200pg HAGG; % inhibition by 
pre-treatment of neutrophils with pHMPSA for 
1 hour at 37°C.
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4.1.6 Effect of Inhibitors on Each Peroxide Product
In order to determine the effect the inhibitors have on each component 
of the phenol red oxidation, the following equations were devised:
1. % Inhibition of oxidation caused by ROOH due to the presence of 
the inhibitor.
Working on the assumption that the presence of catalase prevents any 
of the oxidation of phenol red being due to H^O^ and that ROOH is 
catalase insensitive, then subtracting the catalase sensitive portion 
of the phenol red oxidation from % inhibition for inhibitor + catalase 
gives the effect of the inhibitor on ROOH production. If this is then 
divided by % catalase insensitive, this gives the % inhibition of 
oxidation caused by ROOH in the presence of the inhibitor.
2. • 0 • /
(% Inhibition for inhibitor + catalase - % catalase sensitive) x 100% (A) 
(100% - % catalase sensitive)
2. % Inhibition of oxidation caused by H^Og due to the presence of
the inhibitor.
To determine the effect of the inhibitor on HgOg production, if the 
value obtained in (A) above i.e. the effect of the inhibitor on ROOH 
is subtracted from the value obtained for the % inhibition by inhibitor 
alone i.e. the effect of the inhibitor on both peroxides, then this 
gives the effect the inhibitor must be having on production.
This can then be expressed as a % of the catalase sensitive portion of 
oxidation to give % inhibition of oxidation caused by HgOg due to the 
presence of the inhibitor.
X • 0 • /
(% Inhibition by inhibitor alone - (A)) x 100%
% catalase sensitive
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-6Using figures obtained for inhibition by 10 M pBPB of HAGG-stimulated 
phenol red oxidation as an example (from Figure 4.10)
% Inhibition by pBPB alone = 58%
% Inhibition by catalase alone = 55%
% Inhibition by pBPB + catalase = 84%
Applying equation 1 :
84 - 55 X 100 = 29 x 100 = 64%
100 - 55 45
Applying equation 2:
58 - (84 - 55) X 100 = 29 x 100 = 53%
55 55
Thus applying these equations to the results obtained with all the
inhibitors gives the results shown in Figures 4.12 - 4.13.
The values can be calculated and are shown in Table 4.3. pBPB
and NDGA prove to be the most potent inhibitors of ROOH production
(ED^q = 5 X 10 ^M) and HgOg production (ED^^ = 10 and 4 x 10
respectively). Indomethacin and piroxicam are the weakest inhibitors
-4 -4of ROOH production (ED^^ = 1 0  M and >10 M respectively). Fenclofenac, 
benoxaprofen, indomethacin and piroxicam all seem to have a "negative 
inhibitory" effect on production (see section 4.3).
A summary of the effects the different classes of inhibitors have on 
neutrophil production of ROOH and H^O^ in response to stimulation with 
HAGG or FMLP is shown in Table 4.4. There is an anomaly in the effect 
cyclooxygenase inhibitors have on production depending upon
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™ 5 0 ED50 for
Inhibitor Inhibition of Inhibition of
ROOH H O
(M) (M)
pBPB 5 X  lO"^ 10-®
NDGA 5 X  lO"^ -74 X  10
Diclofenac sodium 6 X  lO"^ 2 X  10'^ *
Fenclofenac - 66  X  1 0 "negative inhibition"
Quinacrine -53 X  10 inactive
Benoxaprofen 2 X "negative inhibition"
Indomethacin 10-4 "negative inhibition"
Piroxicam >10-4 "negative inhibition"
*This is difficult to assess accurately because of its direct effect
-5 -6on the assay (44% inhibition at 6 x 10 M and 9% at 6 x 10 M).
Table 4.3: values for inhibition of both peroxides produced
by HAGG-stimulated neutrophils by various inhibitors.
— 141 —
















Inhibitory "-ve Inhibitory" ----
Phospholipase 
Inhibitors Inhibitory Inhibitory Inhibitory
Table 4.4: Summary of effects classes of drugs have on neutrophil
production of ROOH and H^O^.
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4.2 Structure - Activity Relationships
From these results it would appear that cyclooxygenaseinhibitors are 
having effects on neutrophils unrelated to their ability to inhibit 
cyclooxygenase. It was decided to investigate whether or not these 
effects on neutrophil activity were due to any aspect of their 
structure and thus some analogues of diclofenac sodium and fenclofenac 
were kindly supplied by the manufacturers, Ciba Geigy and Reckitt and 
Coleman. Their effects on neutrophils were tested using the phenol 
red assay and compared with-the marketed compounds.
4.2.1 Diclofenac Analogues
The structures of the analogues are shown in Figure 4.14. The concen-
-6tration chosen was 6 x 10 M. This concentration of diclofenac 
apparently inhibits total phenol red oxidation by 40% (Figure 4.2) but 
only affects the assay directly by 9% (Figure 4.2).
The ability for the analogues to directly inhibit phenol red oxidation 
was investigated using the method already described. The results are 
shown in Table 4.5 and compared with the effect of diclofenac sodium 
itself on the assay at the same concentration. These results show 
that all the analogues have a similar effect on the assay to diclofenac 
sodium except analogue 2 which has a marked direct inhibitory effect 
on the oxidation of phenol red by HgOg.
The analogues were then incubated at 5 x 10 M with 2 x 10 neutrophils 
stimulated with 200^g HAGG or FMLP 20^M for 30 minutes at 37°C in the 
presence or absence of catalase. The results for % inhibition of total 
phenol red oxidation and % inhibition of ROOH production and H^O^ 
production are shown in Table 4.5.






Analogue R1 R2 R3 R4 R5
Diclofenac H 2-Cl H 6-Cl H
2 H 2-CH 3 H 5-CH3 H
6 H 2-Cl 4-OCH3 6-Cl H
7 H 2-Cl H 6-Cl Cl
15 H 3-CF3 H 5-CF3 H
18 CH3 2-Cl H 6-Cl H
19 H 2-Cl H H H
20 H 2-Cl 4-Cl H H
21 H 2-Cl 3-Cl H H
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These results show that analogues 15, 19 and 21 are much less potent 
than diclofenac at overall inhibition of phenol red oxidation and they 
are also the only analogues to have a 'negative inhibitory' effect on 
HgOg production. Analogue 15 is the only analogue to show a lower 
potency at inhibiting ROOH production. Analogues 6, 7, 18 and 20 are 
approximately equipotent with diclofenac. The true effect of analogue 
2 is difficult to assess because of its marked direct effect on the 
assay.
4.2.2 Fenclofenac Analogues
The structures of the analogues are shown in Figure 4.15. The concen-
-4tration chosen was 1.6 x 10 M. As with the diclofenac analogues, the 
direct effect on the assay was investigated but, in common with 
fenclofenac, none of the analogues had any direct effect on the oxi­
dation of phenol red by HgOg in repeated experiments.
“4 6The analogues were then incubated at 1.6 x 10 M with 2 x 10 neutro­
phils stimulated with 200pg HAGG or FMLP 20jiM for 30 minutes at 37°C 
in the presence or absence of catalase. The results for % inhibition 
of total phenol red oxidation and % inhibition of ROOH production and 
HgOg production are shown in Table 4.6.
Analogues 3 and 4 are more potent than fenclofenac at inhibiting over­
all phenol red oxidation as well as ROOH production and HgOg production 
due to both stimuli. Analogue 3 is particularly potent at inhibiting 
HgOg production from FMLP-stimulated neutrophils, achieving 98% 
inhibition. The other analogues are all equipotent, except that 1,
2 and 8 are more potent at inhibiting HgOg production due to stimula­
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4.3 The Effect of Drugs on Resting Cells
The "negative inhibitory" effects obtained with some inhibitors on 
HgOg production was puzzling. None of the results with inhibitors had 
been corrected for resting cell production of because, although
in general this level was very small in comparison with the stimulated 
levels, it was considered invalid to correct for resting cell levels 
when it was not known what effect the inhibitors would have on resting 
cells. However, the "negative inhibitory" results obtained suggested 
that maybe the inhibitors were actually stimulating resting cells to 
produce HgOg, but not ROOH as there were no "negative inhibitory" 
results obtained for ROOH production.
To investigate this possibility, 2 x 10^ neutrophils were incubated in 
the presence and absence of a range of concentrations of inhibitors 
but in the absence of other stimuli for 30 minutes at 37®C in buffered 
phenol red solution. As the absolute amounts of HgOg generated were 
small, any % change in absorbance due to the inhibitors was noted.
The results are shown in Figure 4.16. Benoxaprofen proved very potent 
at stimulating increased phenol red oxidation with indomethacin and 
fenclofenac also having this effect. Piroxicam showed some slight 
stimulatory activity. However, diclofenac, pBPB and NDGA all inhibited 
phenol red oxidation.
Comparing this figure with Figure 4.13, the results mirror very
accurately what could be predicted, although benoxaprofen is more
stimulatory than would be expected from Figure 4.13, increasing
-4absorbance readings by almost 300% at 5 x 10 M. As would be expected
from Figure 4.13, NDGA proved to be the most potent inhibitor of phenol
-6red oxidation, inhibiting absorbance readings by almost 80% at 10 M 
-7and by 20% at 10 M.



























Drug Concentration (m )
Figure 4.16 % change in absorbance readings at 6^0nm
due to presence of drugs with 2 x 10 
resting neutrophils. Results expressed 
X ± SD of 3 experiments.
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oxidation, proving that resting cells produce only and not ROOH
and that the inhibitors only stimulated additional release of H^O^ 
and not ROOH.
4.4 Ferrithiocyanate Assay
This assay for H^O^ was used in comparative experiments with the phenol 
red assay. Using both assays and neutrophils from the same individuals, 
resting cell levels of HgOg production and HAGG-stimulated levels of 
HgOg production after 30 minutes incubation at 37®C were measured.
These always correlated extremely well. The results from one such 
experiment are shown in Table 4.7. This demonstrates that the 
ferrithiocyanate assay measures only H^O^ production as catalase 
inhibits completely any response and the presumed HgOg production in 
the phenol red assay i.e. the catalase sensitive portion of oxidation 
correlates very well with the measured in the ferrithiocyanate
assay.
In order to determine why some inhibitors were directly affecting the 
phenol red assay, they were tested in the ferrithiocyanate assay. 
Unfortunately the inhibitors which were not water-soluble and had been 
dissolved in DMSO still could not be tested as the presence of 1% v/v 
DMSO itself affected this assay. Ethanol and methanol had the same 
effect and so could not be used as solvents for these particular 
inhibitors. However, the water-soluble inhibitors diclofenac sodium, 
quinacrine and BW 755C could all be tested.
—4It was found that none of the concentrations of diclofenac (6 x 10 M
-7 -4 -5- 6 X 10 M) or quinacrine (10 M - 10 M) had any direct effect on
this assay. Although BW 755C still had a direct inhibitory effect on 
the assay, it was to a much smaller extent than on the phenol red 
assay. This proves that none of these inhibitors directly affect the









Resting cells 5 5.5
Resting cells + 
1500U catalase 0 0
Cells + 200|ig HAGG 17.5 8
Cells + 200|ig HAGG 
+ 1500U catalase 8.5 0
Catalase-sensitive g 8response to HAGG
Table 4.7; Resting cells and stimulated cells incubated in 
both the phenol red and ferrithiocyanate assays.
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assay by breaking down HgOg, otherwise it would be expected that they 
would affect both assays to the same extent. The two remaining 
inhibitors which directly affected the phenol red assay, but which 
were not water-soluble, were pirprofen and NDGA. The relevant concen­
trations of these inhibitors were dissolved in the TCA used to 
acidify the ferrithiocyanate assay and were tested in the assay in 
this way. Neither proved to have any effect on the assay.
To investigate further the nature of the interaction of diclofenac 
and pirprofen with the phenol red assay, these inhibitors were incu­
bated with 8.5 Units/ml peroxidase in the ferrithiocyanate assay for 
10 minutes at 37°C in the presence of This was in order to
determine whether they interfered with the phenol red assay by 
inhibiting peroxidase. If this was the case one would expect that the 
peroxidase would fail to break down HgOg in the presence of the 
inhibitors and thus more HgOg would be detected in the assay than when 
peroxidase but no inhibitor was present. It appeared that, in fact, 
both inhibitors acted as an alternative substrate for peroxidase and 
were oxidized themselves by the enzyme in the presence of 
Virtually no HgOg was detected following incubation and yellow 
precipitates were formed in. the reactions containing inhibitor, 
and peroxidase.
4.5 Effects of Inhibitors on Enzymatically-Generated Superoxide
All the inhibitors were tested to determine whether they were capable 
of scavenging superoxide anion, thereby preventing its dismutation to 
HgOg and explaining their ability to inhibit ^<^2 Production. Using 
the microassay technique described in Chapter 2, xanthine and xanthine 
oxidase were used to generate superoxide anion, detected by the reduc­
tion of cytochrome C, in the presence of a range of concentrations of
- 153 -
Drug Concentration(M)
% of reduction of 
cytochrome C 
î n absence of drug 
X ± SD n = 6
Diclofenac -46.3 X 10 52 ± 9
6.3 X lO"^ 68 ± 17
6.3 X lO"^ 80 ± 15
6.3 X 10"7 88 ± 11
Indomethac in 3 X ICT^ 61 ± 25
3 X 10“^ 85 ± 13
3 X 10“^ 88 ± 14
3 X 10“^ 86 ± 10
Fenclofenac 3 X ICT^ 78 ± 18
3 X lO”^ 89 ± 11
3 X 10-G 97 ± 3
Piroxicam 10-4 99 ± 8
10-5 107 ± 15
10-5 107 ± 16
Pirprofen 10-3 65 ± 20
10-4 87 ± 14
10-5 93 ± 11
10-5 91 ± 16
NDGA 5 X 10-5 69 ± 14
10-5 86 ± 13
5 X ICT^ 100 ± 1
10-7 95 ± 10
Benoxaprofen 5 X 10-4 86 ± 16
10-4 76 ± 10
5 X 10-5 86 ± 13
10-5 93 ± 11
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Drug Concentration(M)
% of reduction of 
cytochrome C 
jji absence of drug 
X ± SD n = 6
BW 755C 10-4 80 ± 13
10-5 80 ± 11
10-5 72 ± 17
10-7 78 ± 19
pBPB 10-5 83 ± 19
5 X 10-5 85 ± 16
10-5 90 ± 13
5 X 10-7 89 ± 7
Table 4.8 The effect of drugs on enzymatically-produced superoxide
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inhibitors. The results are shown in Table 4.8 and are expressed as a 
% of the reduction of cytochrome C in the absence of any inhibitor.
The results indicate that the highest concentrations of diclofenac 
sodium, indomethacin, fenclofenac, pirprofen and NDGA may scavenge 
superoxide, although the possibility that they may in fact be inhibiting 
xanthine oxidase cannot be ruled out. However, more importantly, any 
slight scavenging effects these drugs are having does not explain the 
much larger inhibitory effects that NDGA and pBPB have on HgOg 
production by neutrophils (Figure 4.13) and do not interfere with the 
ability of fenclofenac, indomethacin and benoxaprofen to stimulate 
HgOg production by resting neutrophils.
Structures of the Inhibitors
For comparative purposes, the molecular structures of the inhibitors 
used during the course of this work, together with that of phenol red, 
are shown in Figures 4.17 and 4.18.
The Effects of Piroxicam and Diclofenac on Neutrophil Activity In Vivo
In order to determine whether or not either of these NSAIDS had any 
effect on neutrophil activity in vivo, neutrophils were tested from 
patients before and after receiving either piroxicam 20mg daily or 
diclofenac lOOmg in a slow-release preparation daily for four weeks.
A total of 14 patients were studied, 3 male and 11 female, age range 
35 - 75. Three of the patients had early synovitis and the remainder 
had osteoarthritis. Four of the osteoarthritis patients received both 
piroxicam and diclofenac, separated by one week's washout with parace­
tamol. The remaining patients were tested before and after one drug 
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Figure 4.18 Molecular structures of compounds used in this study,
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paracetamol and then on the last day of four weeks treatment with 
either diclofenac or piroxicam. The osteoarthritis patients formed 
part of a double-blind study and thus individual treatment was unknown 
until after completion of this study. It was known that the early 
synovitis patients were receiving piroxicam.
Levels of HgOg and ROOH secretion from 2 x 10^/ml neutrophils were
measured using the phenol red assay following incubation at 37°C for 
30 minutes. Cells were either unstimulated or else stimulated with 
HAGG (2QÜM.g/ml) or FMLP (20iiM) . Figures 4.19 - 4.22 show the results
from this study. Lines connect the results for an individual before
taking the drug and then after 4 weeks drug treatment. It is obvious 
from all these figures that neither piroxicam nor diclofenac affect 
HgOg or ROOH production by unstimulated neutrophils or by those 
stimulated by either HAGG or FMLP. An attempt was made to correlate 
efficacy of drug with effect on neutrophil activity. The osteoarthritis 
patients had been asked to assess efficacy by scoring the drug as 1 - 
excellent down to 4 - poor and by estimating a pain score (visual 
analogue scale) judged by morning and evening pain and pain at rest. 
However, no correlation was found between the apparent effectiveness of 
either drug based on these criteria and its effects on neutrophil 
activity.
Reproducibility of the Phenol Red Assay
The validity of comparing neutrophil activation in the same individual 
over a time period can be assessed by testing the reproducibility of 
the assay. This may be done by examining the levels of HgOg and ROOH 
produced by stimulated neutrophils from the same individual on different 
occasions. The amounts of ROOH produced in response to HAGG and 













Figure 4.19 ^2^2 Production by unstimulated neutrophils from patients
taking piroxicam 20mg od and diclofenac lOOmg od for 4 
weeks. Lines connect the results for an individual 















Figure 4.20 ^2^2 Production by HAGG (200|ig)-stimulated neutrophils
from patients taking piroxicam 20mg pd and diclofenac 
lOOmg od for 4 weeks. Lines connect the results for 
an individual before taking the drug (t=0) and then 























Figure 4.21 ROOH production by HAGG (200|ig)-stimulated neutrophils 
from patients taking piroxicam 20mg od and diclofenac 
lOOmg od for 4 weeks. Lines connect the results for 
an individual before taking the drug (t=0) and then 


















Figure 4.22 production by FMLP (20iiM)-stimulated neutrophils
from patients taking piroxicam 20mg od and diclofenac 
lOOmg od for 4 weeks. Lines connect the results for 
an individual before taking the drug (t=0) and then 
after 4 weeks drug treatment (t=4).
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when the individual was first tested. The mean ± SD of these %s can be 
taken and the nearer this is to 100%, the more reproducible the assay. 
Studying 12 individuals whose neutrophils had been stimulated with HAGG 
to produce ROOH on more than one occasion resulted in a mean value of 
% original ROOH production of 83 ± 35%. Studying 6 individuals whose 
neutrophils had been stimulated with FMLP to produce H^O^ on more than 
one occasion resulted in a mean value of % original production of
91 ± 28%. Certainly a range of 2 SDs from these figures would encompass 
the % change in stimulated levels of ROOH or H^O^ production seen in 
the 4 patients tested after receiving both diclofenac and piroxicam.
The large standard deviations may be explained because the absolute 
values are small (usually less than lOnmoles) and thus % changes tend 




5. INVESTIGATION INTO THE OXIDATIVE METABOLISM OF NEUTROPHILS FROM 
PATIENTS WITH PROGRESSIVE SYSTEMIC SCLEROSIS (PSS)
It has been suggested in the Introduction to this thesis that it is 
possible that oxygen-derived free radicals released from phagocytic 
cells could be implicated in certain features of PSS including damage 
to vascular endothelium, abnormal function of serum protease inhibitors 
and increased frequency of chromosome breakage. Accordingly, and
ROOH production was determined using the phenol red assay in 16 patients 
with PSS, 16 healthy volunteers, 15 patients with RA and 8 patients 
with peripheral vascular disease. Measurements were made on unstimulated 
neutrophils and following incubation with HAGG or with FMLP for 30 
minutes at 37®C.
PSS Patients
16 patients were studied, 15 females and 1 male, age-range 2 9 - 8 2  
years. There were 5 patients receiving penicillamine 3 receiving 
NSAIDS, 3 receiving colchicine, 1 receiving prednisolone and 5 receiving 
no therapy. 10 patients had localized disease, a limited form of PSS 
with features to satisfy the criteria for the CREST variant of the 
disease and 6 patients had diffuse scleroderma, as assessed by Dr. P. J. 
Maddison.
Healthy Volunteers
16 healthy volunteers were studied, 15 females and 1 male, age range 
26 - 73 years. One volunteer was receiving treatment with indomethacin. 
Experiments using neutrophils from PSS patients and healthy volunteers 
were performed at the same time in age-and sex-matched pairs.
-  1 6 5  -
Rheumatoid Arthritis Patients
15 patients were studied, 13 females and 2 males, age-range 37 - 74 
years. There were 5 patients receiving penicillamine, 9 receiving 
NSAIDS, 1 receiving prednisolone and 3 receiving no therapy. They 
all had active joint disease at the time of the study, but none had 
evidence of systemic features such as vasculitis.
Peripheral Vascular Disease Patients
8 patients were studied with atherosclerosis, 5 females and 3 males, 
age-range 56 - 87 years. There were 5 patients receiving diuretics,
1 receiving prednisolone and 1 receiving hypoglycaemic therapy.
HgOg production in 30 minutes by 1 x 10^ unstimulated neutrophils for 
all four groups is shown in Figure 5.1. Unstimulated cells from PSS 
patients produced significantly more than those of any other
group (p<0.05). Moreover, in 12/16 cases, on a given day, the PSS 
patient's neutrophils produced more ^2^2 ^han the healthy control's 
neutrophils. 3 matched pairs produced virtually the same amount and
in only 1 pair did the healthy control's neutrophils produce more 
than the PSS patient's neutrophils. This matched pair data is shown 
in Figure 5.2.
ROOH production in 30 minutes by 1 x 10^ neutrophils stimulated by HAGG 
for all four groups is shown in Figure 5.3. Neutrophils from PSS 
patients generated significantly more ROOH than did the control groups 
(p<0.005). RA patients' neutrophils produced significantly less ROOH 
than healthy controls (p<0.05). ^2^2 Production over and above
unstimulated cell levels in response to HAGG was not studied. In 
Chapter 3, Figure 3.15 showed that when 1 x 10^ neutrophils are 
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HEALTHY n= 16 PSS n= 16 RA n = 15 VASC.DIS. n = 8
Figure 5.1 ^2^2 secreted by unstimulated cells (nmol/10 neutro­
phils/30 minutes) from healthy volunteers and patients 
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n =  16
PSS 
n =  16
RA 
n =  15
VASC. DIS. 
n =  8
Figure 5.3 ROOH secreted by neutrophils stimulated by 200iig
HAGG (nmol/10^ neutrophils/30 minutes) from 
healthy volunteers and patients with PSS, RA 












n =  16
PSS 
n =  16
RA 
n =  15
VASC. DIS. 
n =  8
Figure 5.4 ^2^2 secreted by neutrophils stimulated by FMLP
(20|iM) (nmol/10^ neutrophils/30 minutes) from
healthy volunteers and patients with PSS, RA 
and peripheral vascular disease.
-  170 -
HgOg, and that 92% is due to ROOH. Thus the absolute amounts of HgOg 
produced in these experiments were very small. In contrast, it can be 
seen in Figure 5.4 that following stimulation with FMLP, there was no 
significant difference between any of the groups in the amount of HgOg 
generated in 30 minutes by 1 x 10^ neutrophils above unstimulated 
levels. As the enhanced neutrophil activity appeared to be detectable 
with HAGG as the stimulus, but not with FMLP, it was decided to study 
the Fc receptors on the neutrophils from PSS patients, employing an 
EA rosetting technique described in Chapter 2. Figure 5.5 shows the 
% rosetting cells from healthy controls and from patients with PSS at 
various dilutions of IgG on a log scale. There is a significant shift 
to the right of the line for patients' cells (p<0.01 at 1/500 and 1/750
dilutions). This shift is by a factor of approximately 2.
Moreover, if levels of % rosetting cells at 1/500 dilution of IgG for
a particular individual, are plotted against the amount of
produced in 30 minutes by 1 x 10^ unstimulated cells from that same 
individual, there is a strong positive correlation, with a value of 
the correlation coefficient r, of 0.93 (Figure 5.6). In addition, 
plotting the % rosetting cells at 1/500 dilution of IgG against the 
amount of ROOH produced by HAGG-stimulated neutrophils from the same 
individuals, also gives a strong positive correlation, with a value of 
the correlation coefficient r, of 0.85 (Figure 5.7).
Correlation with Disease Activity
The mean values for HgOg production by unstimulated cells and ROOH 
production by HAGG-stimulated cells for the localized and diffuse 
types of the disease, both active and inactive are shown together with 
the equivalent values for healthy control cells in Table 5.1.

















Figure 5.5 % EA-Rosetting cells from A  healthy controls and ▲
PSS patients at various dilutions of IgG.










Resting Cell H,0, Secretion
(nmol/10* PMN/30 mins)
Figure 5.6 Correlation between % EA-Rosetting cells at IgG 
dilution V s O O  and unstimulated neutrophil 
secretion (nmol/10^ neutrophils/30 minutes).
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HAGG - Stimulated ROOH Secretion
(n mol/10* PMN/30 mins)
Figure 5.7 Correlation between % EA-rosetting cells at IgG 
dilution V s O O  and 200)ig HAGG-stimulated ROOH 
secretion (nmol/10^ neutrophils/30 minutes).














=2°2 10.5 ± 3 7.6 ± 3 4.5 ± 4 5 ± 6 4.3 ± 2.5
ROOH 12.5 ± 5 12 ± 3 7.5 ± 7 16 ± 10 5.6 ± 3
Table 5.1 Mean values (± SD) of production by unstimulated
cells and ROOH production by HAGG-stimulated cells in 
the different disease groups within the PSS patient 
group compared with those for normal cells.
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There is a significant difference between production by unstimu­
lated cells from both active (p<0,01) and inactive (p<0.05) CREST 
patients compared with healthy controls, and also between ROOH 
production by HAGG-stimulated cells from both active (p<0.01) and 
inactive (p<0.01) CREST patients compared with healthy controls. There 
is no significant difference between HgOg production or ROOH production 
by unstimulated cells or HAGG-stimulated cells from both active and 
inactive diffuse disease patients compared with healthy controls. 
However, there is no significant difference between CREST and diffuse 
forms of disease in either HgOg or ROOH production, comparing them 
both as whole groups or divided into active and inactive disease. This 
is presumably due to the small numbers involved. Thus it seems that 
the significant difference seen between the whole PSS group and controls 
for HgOg and ROOH production is due to those patients in the group with 
CREST rather than diffuse disease.
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CHAPTER SIX
DISCUSSION
D I S C U S S I O N
When human phagocytic cells are activated, they respond by producing 
oxygen-derived free radicals; 0^* and HgOg and also another peroxide, 
designated ROOH. The peroxides can be measured by the oxidation of 
phenol red in a peroxidase-dependent reaction and O^* can be measured 
by the reduction of cytochrome C. The H^O^ produced can also be 
detected, although not quantitatively, by its ability to oxidize serum 
SH groups. The increase in oxygen-uptake by these cells which occurs 
upon activation can also be determined using an oxygen electrode.
The major product of oxidative metabolism and its absolute amount 
varies with the type of cell and the stimulus employed, both in terms 
of its structure and concentration. The stimulus also determines the 
kinetics of generation of the products, also depending upon its 
concentration. Unstimulated neutrophils secrete only Og'/HgOg. Those 
stimulated with FMLP produce mainly Og'/HgOg with only minimal amounts 
of ROOH. However, HAGG- and opsonized zymosan-stimulated neutrophils 
secrete mainly ROOH with very little ^2*^^2^2 generated. The
proportion of ROOH produced in response to HAGG is greater at low cell 
numbers. This pattern is repeated with monocytes, except that these 
cells secrete a higher proportion of H^O^ than ROOH compared with 
neutrophils in response to HAGG and opsonized zymosan. However, 
neutrophils generate more HgOg in absolute terms than do monocytes in 
response to all stimuli.
The results shown in Chapter 3 of this thesis indicate that all the 
HgOg that is produced in response to a given stimulus is generated in 
the first few minutes of incubation and thereafter no more is produced. 
In contrast ROOH is produced after an initial lag period and continues 
to be produced at the same rate throughout the incubation period. This 
can be supported further by reference to the results for overall
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peroxide production by the individual stimuli. FMLP-stimulated 
neutrophil production of peroxide (all HgOg) occurs at a faster rate 
than that following opsonized zymosan-stimulated production of 
peroxide (mainly ROOH). Neutrophils stimulated with low concentrations 
of HAGG produce more HgOg than ROOH, but this production falls at 
higher concentrations of HAGG, whereas ROOH production continues to 
increase. Similarly, 0^* production falls at higher concentrations 
of HAGG. This may be due to scavenging of O^ " by HAGG before it 
can be detected by reducing cytochrome C.
Comparing absolute amounts of oxygen consumed,Og" generated and 
subsequent HgOg production, there are apparent discrepancies in the 
values which could be predicted from the equations :
20^ + NADPH  NADPH oxidase--- ^ + NADP"^ + h '̂
It can be deduced from these equations that 1nmole of oxygen yields 
1nmole O^" and 2nmoles * yield 1nmole . However, results shown
in Chapter 3 indicate that 2 x 10^ neutrophils stimulated with 200|J.g/ml 
HAGG consume, in 10 minutes, 90nmoles oxygen, yet produce only l.Snmoles 
0^* and 4.5nmoles HgOg. It is obvious that insufficient superoxide 
is being detected to account for the measured. This could be
because it is dismutating into H^Og before it can reduce the 
cytochrome C; reacting with/scavenged by HAGG before it can reduce the 
cytochrome C; or else it is remaining bound to the enzyme system and 
hence it is unavailable to reduce cytochrome C. Also from these 
equations it can be seen that ten times more oxygen is being consumed 
than is required to produce 4.5nmoles HgOg. As virtually all the
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oxygen consumed by the neutrophil goes toward oxygen-derived free 
radical production, this suggests that 90% of the HgOg generated is 
not secreted. However, this amount is not detected even in lysed 
cells presumably because it is destroyed intracellularly by glutathione 
peroxidase, catalase or myeloperoxidase. It is interesting to note 
that Root et al (1975) found that, in response to a phagocytic stimulus, 
oxygen consumption by neutrophils was approximately 64nmoles, whereas 
HgOg production was only 4 nmoles i.e. eight times more oxygen was 
being consumed than is required to produce 4nmoles - not dissimilar
to the results presented here. Moreover, if the oxygen regenerated by 
superoxide dismutase is taken into account, this means that sixteen 
times more oxygen was being consumed than is required to produce 
4nmoles . However, this is only a valid consideration if the
dismutation occurs extracellularly and the oxygen is not produced 
intracellularly. When Root and Metcalf (1977) added ImM azide to 
inhibit catalase and myeloperoxidase, apparent HgOg release doubled 
and the molar relationships for oxygen consumed, * and HgOg release 
were found to be 1.00: 0.34: 0.51. Furthermore, by using cytochalasin 
B-treated cells an agent that inhibits phagocytosis whilst permitting 
oxidative metabolism to occur, they were able to show that all the oxygen 
taken up during the respiratory burst was converted to by dismu-
tation and that this dismutation reaction was the only important source 
of HgOg generated during the burst.
The use of inhibitors of arachidonic acid metabolism helps to eluci­
date the possible identity of ROOH. From the results shown in Chapter 
4 it can be seen that the most potent inhibitors of ROOH production 
are the phospholipase inhibitor pBPB and the lipoxygenase inhibitor 
NDGA. Cyclooxygenase inhibitors are comparatively inactive. This 
would support the conclusion that the unknown peroxide is a product 
of arachidonic acid metabolism (due to the potent inhibition by pBPB)
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and moreover that it is a product of the lipoxygenase pathway, as 
NDGA is as potent an inhibitor as pBPB, It has already been discussed 
in the Introduction that human neutrophils metabolize arachidonic acid 
mainly via the 5-lipoxygenase pathway and very little is metabolized 
via the cyclooxygenase pathway. As the oxidant of phenol red is 
undoubtedly a peroxide, because it is a peroxidase-dependent reaction, 
this means that ROOH is most likely to be the 5-hydroperoxy derivative 
of arachidonic acid, 5-HPETE. The fact that monocytes produce a 
higher proportion of HgOg than ROOH compared with neutrophils indicates 
that they either have less lipoxygenase enzyme than neutrophils or 
that they metabolize more arachidonic acid via the cyclooxygenase 
pathway than do neutrophils. It would have been more satisfactory to 
have performed experiments attempting to detect LTB^ to prove this 
hypothesis more conclusively. This would have involved the use of 
radio-labelled exogenous arachidonic acid for neutrophils to metabolize 
(and there is no guarantee that exogenous arachidonic acid would give 
the same products as endogenous arachidonic acid) and the subsequent 
isolation of labelled LTB^ using thin layer chromatography techniques. 
If ROOH is 5-HPETE one might expect the mixed cyclooxygenase/lipoxy- 
genase inhibitor benoxaprofen to prove more potent in inhibiting ROOH 
release than in fact it is. However, it may be that benoxaprofen is 
more potent as a cyclooxygenase inhibitor than a lipoxygenase inhibitor, 
In fact the concentrations used by Harvey et al (1983), using guinea- 
pig peritoneal cells as a source of 5-lipoxygenase, to inhibit produc­
tion of 5-HETE, were 2 x 10 (95% inhibition) to 3 x 10 (61%
inhibition). This compares with the results presented in this thesis
-3of 97% inhibition of ROOH production at 10 M and 45% inhibition at 
-510 M. Thus the concentrations used to demonstrate its ability to 
inhibit 5-lipoxygenase are similar to those used in this work.
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Benoxaprofen does inhibit ROOH production at concentrations found 
to inhibit 5-lipoxygenase. If it does not inhibit 12- and 15-lipoxy­
genases, as Harvey et al found (1983), then ROOH must be derived from 
the 5-lipoxygenase enzyme. Alternatively this might suggest that 
it is 15-HPETE rather than 5-HPETE that is being detected. However, 
as the amount of human neutrophil 15-lipoxygenase is very small 
compared with 5-lipoxygenase, this would seem unlikely (Naccache and 
Sha'afi, 1983).
The ability of HAGG and opsonized zymosan, but not apparently FMLP, 
to stimulate 5-HPETE production needs to be considered further. It 
could be that as different concentrations of HAGG stimulate neutrophils 
to produce the two peroxides in different proportions, different 
concentrations of FMLP or opsonized zymosan would also generate 
different proportions of products. For instance, a higher concentration 
of FMLP than 20|iM may generate 5-HPETE as well as HgOg and a lower 
concentration of opsonized zymosan than 800|ig/ml may generate a higher 
proportion of HgOg. Thus there is no reason to suppose that FMLP 
does not stimulate either human monocytes or neutrophils to produce 
leukotrienes, nor to suppose that unstimulated cells do not produce 
leukotrienes. In fact. Ham et al (1983) have demonstrated that indeed 
FMLP does stimulate LTB^ production, but in pmol/10^ cells quantities. 
These amounts, detected using sensitive HPLC techniques, are obviously 
too small to be detected using the much cruder, less sensitive phenol 
red assay. However, Clancy, Dahinden and Hugli (1983) found that FMLP 
does not stimulate LTB^ production by neutrophils from endogenous 
arachidonic acid, only via exogenous sources, and also that unstimu­
lated cells do not produce LTB^. Similarly, Palmer and Salmon (1983) 
were able to demonstrate LTB^ release by human neutrophils in response
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to opsonized zymosan but not in response to FMLP. Williams, Czop
and Austen (1984) have also shown that human monocytes release
quantitatively more leukotrienes following stimulation with opsonized
zymosan than with IgG-coated erythrocytes. This also fits the
pattern of ROOH release in this study. The ability of HAGG and
opsonized zymosan but not FMLP to stimulate 5-HPETE release may be
explained by considering the type of stimuli they are. The large,
particulate, membrane-perturbing stimulus of HAGG or opsonized
zymosan is going to be a much more powerful stimulus, involving
stimulating every appropriate receptor on the neutrophil surface, than
the soluble FMLP stimulus. Thus it is possible that stimulation of the
NADPH oxidase does not need such a gross effect on the neutrophil as
activation of phospholipase A ^ . This is supported by the fact that
low concentrations of HAGG stimulate mainly production rather
than 5-HPETE. It would have been interesting to use cytochalasin B-
treated cells to see if the pattern of proportion of H O  /5-HPETE
Z 2.
released in response to the various stimuli changed. The lag-time 
associated with 5-HPETE production may indicate that in fact stimula­
tion of phospholipase A^ is dependent upon NADPH oxidase first being 
stimulated to produce Og". However, it is not known, using the rather 
insensitive phenol red assay, whether this lag-time is genuine, or 
whether in the first 2 minutes, quantities of 5-HPETE too small to be 
detected are being produced. In any case, it is obvious that 5-HPETE 
production cannot be dependent upon HgO^ production as it is not 
prevented by catalase. Interaction of any stimulus with its receptor 
leads to a mobilization of intracellular calcium. This in turn is 
involved in activation of protein kinase C which changes the state of 
phosphorylation of an activator protein stimulating NADPH oxidase 
(Rink, Sanchez and Hallam, 1983; Babior, 1984). Intracellular calcium
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also activates phospholipase , stimulating arachidonic acid 
metabolism. It is possible that the former events occur faster than 
the mobilization of phospholipids and release of arachidonic acid, 
thus explaining the lag-time. Certainly the fact that not only do 
pBPB and NDGA inhibit 5-HPETE production, but also that their ED^^ 
values are similar for inhibition of both HAGG- and FMLP-stimulated 
production of HgOg indicates that a common mechanism of activation is 
involved.
Although the cyclooxygenase inhibitors are not as potent as phospholi­
pase A^/lipoxygenase inhibitors at suppressing ROOH production, none­
theless they do have some ability in this direction except for 
piroxicam. If ROOH is 5-HPETE, this is surprising especially as 
several investigators have shown that in fact cyclooxygenase inhibitors 
appear to stimulate metabolism of arachidonic acid via the lipoxygenase 
pathway by human neutrophils (Harvey et al, 1983; Myers and Siegel, 1983), 
This is thought to be due either to the shunting of arachidonic acid 
to the lipoxygenase pathway following inhibition of cyclooxygenase, or 
to the fact that prostaglandins, which would normally inhibit LTB^ 
release, are not present (Ham et al, 1983). The effect of these drugs 
on ROOH release must be unrelated to their action as cyclooxygenase 
inhibitors, and neither are they lipoxygenase inhibitors, but rather 
to another effect of the drugs on these cells. This is more marked 
with neutrophils as the effects of diclofenac sodium on monocytes were 
negligible. As well as the inhibitory effects of cyclooxygenase 
inhibitors on 5-HPETE production, all inhibitors demonstrate activity 
on HgOg production by neutrophils stimulated with either HAGG or FMLP. 
Most of the NSAIDS inhibit FMLP-stimulated production but
apparently not HAGG-stimulated production except for diclofenac
sodium. It is obvious from the experiments with the drugs and 
enzymatically-generated 0^“ that it is unlikely that the inhibitory drugs
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are affecting HgOg production merely by scavenging Possibly the
effects of these drugs on FMLP-stimulated HgOg production may be 
associated with an inhibition of FMLP binding because, as has been 
discussed in the Introduction, many NSAIDS have been shown to have this 
effect (Abita, 1981; Van Dyke et al, 1982). It would have been more 
satisfactory if time had allowed the use of labelled FMLP to investigate 
this possibility further. Otherwise it is difficult to explain why, 
when FMLP is the stimulus, drugs have the ability to inhibit HgOg 
production, whereas when HAGG is the stimulus, the same drugs stimulate 
HgOg production. However, the results with HAGG-stimulated cells are 
really a summation of two opposing events, namely a) inhibition of HAGG- 
stimulated HgOg production and b) the direct stimulation of HgOg produc­
tion. Certain drugs are capable of both (a) and (b) but diclofenac 
sodium only really does (a). Therefore it appears to be more potent than 
the others but really it is only less directly stimulatory. Various 
analogues of diclofenac sodium and fenclofenac were used to try to 
elucidate any structure/activity relationships for the drug effects on 
neutrophil HgOg/S-HPETE production. Considering the diclofenac series, 
the important factor seems to be the twist in the molecule about the 
imine link dictated by the position of substitution of atoms (i.e. 2,6) 
on the ring remote from the acid. Thus, when this twist can be lost, as 
with the 2-chloro or 2,3-dichloro compounds apparent potency is lost. 
However, again, this is a summation of inhibitory/stimulatory effects.
Any substitution made in the 4-position (Cl or OMe) somewhat enhances 
potency. Any substitution made in the ring containing the acid moiety 
has no effect on activity compared with the original compound. This is 
also the case for substitution in the acid itself (acetic or propionic). 
This is true for both diclofenac and fenclofenac analogues.
As fenclofenac is approximately twenty times less potent than diclofenac 
analogue no. 20, and the only difference in the molecule is the ether
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linkage in fenclofenac rather than the imine linkage, this link must 
be important. As the imine group includes the possibility for 
hydrogen bonding with the carbonyl of the acid group, this would confer 
on the molecule a more rigid structure for the diclofenac series, 
keeping the imine group planar with the acid ring. Also the ether 
link may cause the substituted ring to twist such that it is not in the 
same plane as the acid ring. This has the same effect on the structure 
as the 2,6 substitutions in the diclofenac series and so the substitution 
pattern in the fenclofenac series is less relevant. This explains why 
the 2-chloro and 2,3-dichloro substituted compounds do not show a 
lower potency than fenclofenac, whereas the equivalent compounds in 
the diclofenac series are less potent (or more directly stimulatory) 
than diclofenac. In common with the diclofenac series, a bulky 
substitution in the 4-position, as in the isobutyl-substituted compound, 
increases potency. This may be due to its increased lipophilicity 
allowing greater association with the cell membrane and perhaps inhibi­
ting FMLP binding. It is also interesting to note that in tests of 
anti-inflammatory activity in adjuvant arthritis, this analogue was found 
to be three times more potent than fenclofenac (Atkinson et al, 1983).
It is unfortunate that no correlation between potency in these experi­
ments and potency as anti-inflammatory agents could be made with the 
diclofenac analogues, but such information was not forthcoming from 
the manufacturers.
There is no obvious similarity in structure between the drugs and drug 
analogues which directly stimulate neutrophils which might explain this 
activity. Similarly, there is no obvious correlation between the 
structures of the drugs which interfere with the phenol red assay, or 
between these compounds and phenol red. Substitution of CH^ groups 
instead of chlorine atoms in the diclofenac series results in inter-
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ference with the phenol red assay whereas a similar substitution in 
the fenclofenac series does not have that effect. The drugs appear to 
have this direct effect on the assay due to their ability to act as 
alternative substrates for peroxidase, displacing phenol red and 
being oxidized themselves. Thus peroxidase must have a very open 
catalytic site to be able to interact with such a wide variety of 
structures. The inhibitory effects of these drugs on neutrophil 
activity could be explained in terms of interactions with the cell 
membrane, cross-linking proteins and thus preventing mobilization of 
phospholipids or stimulation of NADPH oxidase. Certainly it has 
been demonstrated that cross-linking agents interfere with the 
activation of NADPH oxidase by reacting with amino groups on the cell 
surface (Aviram, Simons and Babior, 1984). The work with sulphydryl 
group blockers indicates that free SH groups are necessary for activa­
tion of both arachidonic acid metabolism via lipoxygenase and NADPH 
oxidase. Whether these compounds inhibit activity by preventing 
mobilization of essential components of the cell membrane, or whether 
SH groups are a vital structural part of the effector enzymes is not 
clear, but it does demonstrate that an interaction with certain mole­
cular groups on the cell surface can have substantial effects on cell 
activity.
The relevance of all this,work in vivo is questionable because the 
concentrations of free drug in the plasma or synovial fluid is very 
much lower than concentrations employed in most experimental studies, 
as already discussed in the Introduction. As shown here, there is no 
effect on neutrophil activity by either diclofenac sodium or piroxicam 
in vivo and, in any case, piroxicam in vitro has very little effect 
compared with the other cyclooxygenase inhibitors at comparable 
concentrations. Both these observations do not agree with work carried
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out by Weissmann's group (Abramson et al, 1983) who demonstrated that 
piroxicam in vitro inhibited FMLP-stimulated * release and piroxicam 
treatment led to inhibition of FMLP-stimulated production of by 
neutrophils. However this was using a small sample of healthy volun­
teers (age-range unknown) who were taking the drug for 3 days only. It 
is possible that this cannot be compared with a study using mainly 
elderly osteoarthritic patients, where there may have been a problem 
with compliance. Also any inhibitory effects Weissmann's group observed 
with piroxicam may be due to its metabolite, if it does not have any 
effect in vitro. An elderly patient will not metabolise the drug as 
efficiently. It is certainly true that the young early synovitis 
patients' neutrophils did not produce as much in response to
stimulation with FMLP following piroxicam treatment. The ability of 
certain drugs to stimulate neutrophil oxidative metabolism is also 
questionable in vivo due to the concentration factor. It is perhaps 
interesting to note that the two drugs which have this ability at 
physiologically relevant concentrations, benoxaprofen and fenclofenac, 
have both been withdrawn for toxicity reasons. It was intended to 
include fenclofenac in an in vivo study with piroxicam and diclofenac 
to see whether or not its stimulatory activity could be detected, but 
it was withdrawn before this could be achieved. These stimulatory 
effects with benoxaprofen have also been reported by Anderson et al 
(1984), using physiologically relevant concentrations of the drug. They 
suggest that its pro-oxidant activity may explain its anti-inflammatory 
activity by inhibiting neutrophil migration.
Anti-inflammatory drugs may exert some effect by acting as scavengers 
of oxygen radicals rather than by preventing their formation in the 
first place. Although it has been shown here that it is unlikely any 
of the drugs themselves can scavenge enzymatically-generated 0^*,
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it has been found that copper complexes of various NSAIDS can 
eliminate 0^* radicals (Lengfelder, 1984), acting as catalysts of 
O2' dismutation. Moreover such complexes have been isolated in vivo.
Having discussed whether or not NSAIDS can affect oxygen-derived free radical 
production in vivo as opposed to in vitro, does free radical production 
by neutrophils have a major role in inflammation or RA anyway?
Patients with CGD have neutrophils which fail to generate oxygen-derived 
free radicals, and yet these patients have a normal inflammatory 
reaction (Roos and Bragt, 1984). Also neutrophils from patients 
deficient in myeloperoxidase produce more but again have normal 
inflammatory responses (Roos and Bragt, 1984). On the other hand many 
investigators have reported beneficial effects of superoxide dismutase 
in human inflammatory diseases and experimental models of inflammation, 
indicating a role for oxygen-derived free radicals (Goebel, Storck and 
Neurath, 1981) . It should also be remembered that products of lipid 
peroxidation are present in the plasma and synovial fluid of patients 
with rheumatoid disease (Rowley et al, 1984) and also that free radical 
-damaged IgG is found in vivo (Lunec, 1984; Wickens and Dormandy, 1984). 
Another relevant point is that O^* reduces the viscosity of synovial 
fluid. SOD and catalase protect against this as do several NSAIDS 
(McCord, 1974; Puig-Parellada and Planas, 1978).
The work performed with neutrophils from patients with PSS indicates 
that neutrophils from these patients ex vivo are in an activated state, 
producing significant amounts of and 5-HPETE. This correlates
well with increased expression of Fc receptors. Without performing 
Scatchard plot analysis, it is not possible to say conclusively whether 
this is due to increased numbers of receptors, or to an increase in 
receptor avidity. However, as the shift to the right of the graph 
showing % rosetting cells against dilution of IgG for patients is most
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significant at the very weakest dilutions of IgG, the explanation of 
increased numbers of receptors is the more likely. In monocytes, 
increased expression of Fc receptors is indicative of activation and 
indeed it has been found that RA patients' monocytes carry more 
Fc receptors than do healthy controls (Carter et.al, 1984). However, 
no such increase in Fc receptor expression in RA patients' neutrophils 
can be demonstrated (Minty, 1982) and no increase in activity of RA 
patients' neutrophils is shown here.
Thus, neutrophils in the microvasculature of PSS patients are producing 
HgOg which is capable of mediating endothelial cell damage (Weiss et al, 
1981) and could contribute significantly to the vascular pathology of 
this disease. Moreover, the cells are also capable of producing more 
5-HPETE, and hence presumably LTB^, serving to recruit more neutrophils 
by chemotaxis and encouraging increased adherence and margination, 
contributing to cell damage (Samuelsson, 1983; Piper, 1984). However, 
as it has been demonstrated that the proportion of 5-HPETE produced by 
neutrophils falls with increasing cell numbers, it is debatable whether 
this is significant. It must also be borne in mind that PSS is not 
essentially an inflammatory disease and that the involvement of free 
radicals and/or LTB^ must be restricted to possible damage to endothelial 
cells only. As neutrophils from the control group with peripheral 
vascular disease did not show enhanced activity, it must be assumed that 
this phenomenon is not indicative of general vascular disease. An 
interesting patient group to have studied would have been those with 
rheumatoid vasculitis, where there is damage to the vascular endothe­
lium.
It is interesting to speculate on the stimulus that is activating these 
patients' neutrophils in vivo. It may be that the patients whose 
neutrophils were the most active in this study had the highest level of
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circulating immune complexes. It has been found that 20% of patients 
with PSS do have circulating immune complexes (Dr. P. J. Maddison, 
Personal Communication). However, if immune complexes were responsible 
for activation of neutrophils, one would expect to see activated 
neutrophils in patients with RA. Other possible stimuli include LTB^; 
some factor from damaged endothelial cells; or proteases, especially 
as these patients have a functional defect in serum protease inhibitors,
The observation that it is patients with localized disease who appear 
to have the most active neutrophils, rather than those with the more 
serious diffuse disease is surprising. A possible explanation is that 
those with diffuse disease do have more active cells, but these cells 
are so activated that they remain marginated to the endothelium and the 
cells collected in the blood sample are the less activated ones.
Finding activated neutrophils in the vascular system is unusual and may 
be relevant in contributing to the vascular pathology of the disease.
It may be important to treat patients with PSS with drugs that suppress 
neutrophil function or that scavenge oxygen-derived free radicals. It 
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